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A B S T R A C T
Background
The intensive care unit (ICU) stay has been linked with a number of physical and psychological sequelae, known collectively as post-
intensive care syndrome (PICS). Specific ICU follow-up services are relatively recent developments in health systems, and may have
the potential to address PICS through targeting unmet health needs arising from the experience of the ICU stay. There is currently no
single accepted model of follow-up service and current aftercare programmes encompass a variety of interventions and materials. There
is uncertain evidence about whether follow-up services effectively address PICS, and this review assesses this.
Objectives
Our main objective was to assess the effectiveness of follow-up services for ICU survivors that aim to identify and address unmet health
needs related to the ICU period. We aimed to assess effectiveness in relation to health-related quality of life (HRQoL), mortality,
depression and anxiety, post-traumatic stress disorder (PTSD), physical function, cognitive function, ability to return to work or
education and adverse effects.
Our secondary objectives were to examine different models of follow-up services. We aimed to explore: the effectiveness of service
organisation (physician- versus nurse-led, face-to-face versus remote, timing of follow-up service); differences related to country (high-
income versus low- and middle-income countries); and effect of delirium, which can subsequently affect cognitive function, and the
effect of follow-up services may differ for these participants.
Search methods
We searched CENTRAL, MEDLINE, Embase and CINAHL on 7 November 2017. We searched clinical trials registers for ongoing
studies, and conducted backward and forward citation searching of relevant articles.
Selection criteria
We included randomised and non-randomised studies with adult participants, who had been discharged from hospital following an
ICU stay. We included studies that compared an ICU follow-up service using a structured programme and co-ordinated by a healthcare
professional versus no follow-up service or standard care.
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Data collection and analysis
Two review authors independently assessed studies for inclusion, extracted data, assessed risk of bias, and synthesised findings. We used
the GRADE approach to assess the certainty of the evidence.
Main results
We included five studies (four randomised studies; one non-randomised study), for a total of 1707 participants who were ICU survivors
with a range of illness severities and conditions. Follow-up services were led by nurses in four studies or a multidisciplinary team in
one study. They included face-to-face consultations at home or in a clinic, or telephone consultations or both. Each study included at
least one consultation (weekly, monthly, or six-monthly), and two studies had up to eight consultations. Although the design of follow-
up service consultations differed in each study, we noted that each service included assessment of participants’ needs with referrals to
specialist support if required.
It was not feasible to blind healthcare professionals or participants to the intervention and we did not know whether this may have
introduced performance bias. We noted baseline differences (two studies), and services included additional resources (two studies),
which may have influenced results, and one non-randomised study had high risk of selection bias.
We did not combine data from randomised studies with data from one non-randomised study. Follow-up services for improving long-
term outcomes in ICU survivors may make little or no difference to HRQoL at 12 months (standardised mean difference (SMD) -0.0,
95% confidence interval (CI) -0.1 to 0.1; 1 study; 286 participants; low-certainty evidence). We found moderate-certainty evidence
from five studies that they probably also make little or no difference to all-cause mortality up to 12 months after ICU discharge (RR
0.96, 95% CI 0.76 to 1.22; 4 studies; 1289 participants; and in one non-randomised study 79/259 deaths in the intervention group,
and 46/151 in the control group) and low-certainty evidence from four studies that they may make little or no difference to PTSD
(SMD -0.05, 95% CI -0.19 to 0.10, 703 participants, 3 studies; and one non-randomised study reported less chance of PTSD when a
follow-up service was used).
It is uncertain whether using a follow-up service reduces depression and anxiety (3 studies; 843 participants), physical function (4
studies; 1297 participants), cognitive function (4 studies; 1297 participants), or increases the ability to return to work or education (1
study; 386 participants), because the certainty of this evidence is very low. No studies measured adverse effects.
We could not assess our secondary objectives because we found insufficient studies to justify subgroup analysis.
Authors’ conclusions
We found insufficient evidence, from a limited number of studies, to determine whether ICU follow-up services are effective in
identifying and addressing the unmet health needs of ICU survivors. We found five ongoing studies which are not included in this
review; these ongoing studies may increase our certainty in the effect in future updates. Because of limited data, we were unable to
explore whether one design of follow-up service is preferable to another, or whether a service is more effective for some people than
others, and we anticipate that future studies may also vary in design. We propose that future studies are designed with robust methods
(for example randomised studies are preferable) and consider only one variable (the follow-up service) compared to standard care; this
would increase confidence that the effect is due to the follow-up service rather than concomitant therapies.
P L A I N L A N G U A G E S U M M A R Y
Follow-up services to improve the long-term after-effects of a stay in the intensive care unit
What is the aim of this review
More people survive the intensive care unit (ICU), but are prone to suffering from physical and psychological consequences that may
affect their quality of life. Follow-up services are a relatively new development in healthcare. These services, which include consultations
with healthcare professionals, are intended to identify and address these after-effects more effectively than standard care (which does
not use follow-up services). The aim of this Cochrane Review was to find out if follow-up services for people after they have been in
the ICU are effective. We collected and analysed all relevant studies to answer this question and found five studies.
Key messages
Overall, we found few studies, each of which used a different design of a follow-up service, and so our confidence in deciding whether
ICU follow-up services are effective was limited. We found no evidence of whether using a follow-up service after a stay in the ICU
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improves a person’s health-related quality of life, anxiety and depression, post-traumatic stress disorder (PTSD), or physical and mental
function. We found no evidence of whether using a follow-up service reduces the number of people who die or the number of people
who return to work 12 months after ICU discharge.
During our search of the literature, we found five ongoing studies. These are not included in this review, but including them in future
updates may increase the certainty of the evidence and our confidence in deciding whether ICU follow-up services are effective.
What was studied in the review
We studied some of the physical and psychological consequences that people may suffer after they have been in the ICU, which may
affect their quality of life, for example, anxiety and depression, or PTSD. We assessed whether these consequences were improved if a
follow-up service was used.
What are the main results of the review
We found four randomised studies with 1297 participants and one non-randomised study with 410 participants. These studies were
conducted in Denmark, Germany, Sweden, UK and USA. Participants had a range of conditions in the ICU, and varied in severity of
these conditions. One study included only participants who had sepsis.
We included studies that compared a follow-up service provided after a stay in the ICU with standard care (which provided no follow-
up service). Follow-up services were led by nurses in four studies, and by amultidisciplinary team (nurses, doctors, and physiotherapists)
in the fifth study. Consultations were given face-to-face at home or in a clinic, or were made on the telephone, or both. Participants
had more than one consultation as part of the service, and in two studies participants had up to eight consultations. Although the
design of follow-up service consultations differed in each study, we noted that each service included assessment of participants’ needs
with referrals to specialist support if required.
We found that follow-up services may make little or no difference to people’s health-related quality of life 12 months after their stay in
the ICU (1 study; 286 participants; low-certainty evidence), and probably make little or no difference to the number of deaths after
12 months (5 studies; 1707 participants; moderate-certainty evidence). Follow-up services may make little or no difference to PTSD
(3 studies; 703 participants; low-certainty evidence).
We are not confident in the evidence of whether using a follow-up service reduces depression and anxiety (3 studies; 843 participants),
physical function (4 studies; 1297 participants), cognitive function (4 studies; 1297 participants), or increases the ability to return to
work or education (1 study; 386 participants); we assessed this evidence as very low certainty. No studies measured adverse effects.
We had hoped to look at differences between types of ICU follow-up service and between people who may or may not have experienced
delirium, to give us more information about whether certain styles of service are better, or whether these services are more useful for
people with different conditions. However, we found insufficient studies to be able to look at these differences.
How up to date is this review
We searched for studies that had been published up to November 2017.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
ICU follow-up services compared with standard care or no follow-up service for survivors of critical illness
Patient or population: adult survivors of the ICU, excluding those already in an exist ing follow-up or rehabilitat ion programme
Settings: clinics in a hospital or in the part icipant ’s home (via telephone) in: Denmark, Germany, Sweden, UK and USA
Intervention: ICU follow-up service
Comparison: standard care or no follow-up service
Outcomes Effects of follow-up services for
adult survivors of the ICU
Number of participants (studies) Certainty of the evidence
(GRADE)
Comments
Health- related quality of life
Scoring tool: EQ-5D
Direct ion of scale: lower scores
indicate better HRQoL
Time point of measurement: 12
months
Using a follow-up service af ter ICU
discharge may make lit t le or no
dif ference to HRQoL of survivors
of crit ical illness SMD -0.0, 95%
CI -0.1 to 0.1a
286 part icipants
(1 study)
⊕⊕©©
Lowb
All- cause mortality
Time point of measurement: 2
months in 1 randomised study; 12
months in 3 randomised studies;
14 months in 1 non-randomised
study
From 5 studies, we found that
using a follow-up service probably
makes lit t le or no dif ference to the
number of people who die af ter
ICU discharge
We pooled data f rom 4 studies
(RR 0.96, 95% CI 0.76 to 1.22)
1289 part icipants
(4 studies)
⊕⊕⊕©
Moderatec
We did not include data f rom one
non-randomised study in meta-
analysis. Study authors reported
number of deaths in the interven-
t ion group: 79/ 259; and in the con-
trol group: 46/ 151
Depression and anxiety
Scoring tool: HADS-D and HADS-
A
Direct ion of scale: lower scores
indicate less depression and less
anxiety
Time point of measurement: 12
months in 2 randomised studies;
14 months in 1 non-randomised
study
It is uncertain whether using
a follow-up service reduces de-
pression. Est imates f rom 2 ran-
domised studies were SMD -0.1,
95% CI -1.2 to 1.0a ; and absolute
risk reduct ion (usual care vs inter-
vent ion) -0.20, 95% CI -1.12 to 0.
72a ; and 1 non-randomised study
reported lit t le or no dif ference in
scores (women: P = 0.09; men: P
= 0.47)a
1082 part icipants
(3 studies)
⊕©©©
Very lowd
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It is uncertain whether using a
follow-up service reduces anxi-
ety. Est imates f rom 2 randomised
studies were SMD -0.8, 95%CI -1.
9 to 0.4a ; and absolute risk reduc-
t ion (usual care vs intervent ion) -
0.21, 95% CI -1.22 to 0.80a; and
1 non-randomised study reported
no dif ference in scores (women:
P = 0.14; men: P = 0.78)a
Post- traumatic stress disorder
(PTSD)
Scoring tools: DVT, HTQ-IV, IES,
and PTSS-10
Direct ion of scales: lower scores
indicate less distressing symp-
toms of PTSD
Time point of measurement: 12
months in 2 randomised studies;
14 months in 1 non-randomised
study
From 4 studies, it is uncertain
whether using a follow-up service
reduces PTSD
Estimates showed lit t le or no dif -
ference in PTSD in 3 randomised
studies (SMD -0.05, 95% CI -0.19
to 0.10; 702 part icipants)
703 part icipants
(3 studies)
⊕⊕©©
Lowe
We did not include data f rom one
non-randomised study in meta-
analysis. Study authors reported
lower IES scores (indicat ing less
chance of PTSD) in women who
received a follow-up service (P =
0.01)
Physical function
Scoring tool: PCS
Direct ion of scales: higher scores
indicate improved physical func-
t ion
Time point of measurement: at 12
months in 3 randomised studies
(using SF-36), and at 2 months in
1 randomised study (using SF-8)
From 4 studies, it is uncertain
whether using a follow-up service
improves physical funct ion at 12
months
Est imates showed lit t le or no dif -
ference in physical funct ion at 12
months in 2 studies (MD 1.31,
95%CI -0.86 to 3.49)
422 part icipants
(2 studies)
⊕©©©
Very lowg
We did not included data f rom 2
studies in meta-analysis. One of
these studies reported improved
physical funct ion at 2 months in
part icipants who received a fol-
low-up service (P = 0.02)f , and
one reported lit t le or no dif ference
in physical funct ion at 12 months
(P > 0.05)
Cognitive function
Scoring tools: MCS of SF-36 and
SF-8
Direct ion of scales: higher scores
indicate improved cognit ive func-
From 4 studies, it is uncertain
whether using a follow-up service
improves cognit ive funct ion at 12
months
Est imates showed lit t le or no dif -
622 part icipants
(3 studies)
⊕©©©
Very lowg
We did not include data f rom 1
study in meta-analysis. Study au-
thors reported lit t le or no dif fer-
ence in cognit ive funct ion at 2
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t ion
Time point of measurement: at
12 months in 2 randomised stud-
ies and at 6 months in 1 ran-
domised study (using SF-36), and
at 2 months in 1 randomised study
(using SF-8)
ference in cognit ive funct ion at 6
and 12 months in 3 studies (MD
1.44, 95% CI -0.51 to 3.39)
monthsf
Ability to return to work or edu-
cation
(reported at 12 months)
It is uncertain whether using a fol-
low-up service increases the num-
ber of part icipants who are able
to return to work at 12 months
(OR 1.06, 95%CI 0.35 to 3.21)a
386 part icipants
(1 study)
⊕©©©
Very lowh
Adverse effects Not measured - -
CI: Conf idence interval;DTS: Davidson Trauma Scale; EQ-5D: Euroqol-5D; HADS-A: Hospital Anxiety and Depression scale for anxiety;HADS-D: Hospital Anxiety and Depression
scale for depression; HTQ- IV: Harvard Trauma Quest ionnaire Part IV; IES: Impact of Events scale; MCS: mental component score of SF-36; MD: mean dif ference; OR: odds
rat io; PCS: physical component of SF-36; PTSD: post-traumatic stress disorder; PTSS-10: Post Traumatic Symptom Scale; RR: risk rat io; SF-36: 36-item Short Form Survey;
SMD: standardised mean dif ference
GRADE Working Group grades of evidence
High: this research provides a very good indicat ion of the likely ef fect. The likelihood that the ef fect will be substant ially dif f erent is low
Moderate: this research provides a good indicat ion of the likely ef fect. The likelihood that the ef fect will be substant ially dif f erent i is moderate
Low: this research provides some indicat ion of the likely ef fect. However, the likelihood that it will be substant ially dif f erent i is high
Very low: this research does not provide a reliable indicat ion of the likely ef fect. The likelihood that the ef fect will be substant ially dif f erent i is very high
aef fect est imate or P values as reported by study authors.
bIntervent ion group received addit ional therapy (manual-based physiotherapy) which may have inf luenced results; downgraded
by one level for study lim itat ions. One study with few part icipants; downgraded by one level for imprecision.
cAnalysis was at dif f erent t ime points, and we noted some potent ial dif f erences between studies in baseline characterist ics
between studies; downgraded by one level for inconsistency.
d Intervent ion group in one study received an addit ional therapy (manual-based physiotherapy programme), and one non-
randomised study had a high risk of select ion bias; we downgraded by one level for study lim itat ions. Outcomes were
measured at dif f erent t ime points, and we noted some baseline dif ferences between studies; downgraded by one level for
inconsistency. Evidence was f rom few studies; downgraded one level for imprecision.
eIntervent ion group in one study received an addit ional therapy (manual-based physiotherapy programme), and one non-
randomised study had a high risk of select ion bias; downgraded by one level for study lim itat ions. We noted dif ferences at
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baseline in one non-randomised study (more women in control group had a previous history of psychological problems) which
may have inf luenced results for this outcome, and we noted inconsistent results between three combined randomised studies
and one non-randomised study; we downgraded one level for inconsistency.
f data re-analysed by study authors account ing for death.
g Intervent ion group in one study received an addit ional therapy (manual-based physiotherapy programme), and in another
study intervent ion group were also involved in preparat ion of a discharge summary plan; downgraded one level for study
lim itat ions. Outcomes were measured at dif f erent t ime points, we noted some baseline dif ferences between studies, and we
noted a wide conf idence interval in analysed data; downgraded by two levels for inconsistency.
hIntervent ion group received addit ional therapy (manual-based physiotherapy) which may have inf luenced results; downgraded
by one level for study lim itat ions. One study with few part icipants and we noted a wide conf idence interval; downgraded by
two levels for imprecision.
isubstant ially dif f erent = a large enough dif ference that it m ight af fect a decision.
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
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B A C K G R O U N D
In 2014 to 2015, approximately 150,000 patients were admit-
ted to adult intensive care units (ICUs) or high-dependency units
(HDUs) in England, Wales and Northern Ireland, and approxi-
mately 45,000 patients in Scotland, a large percentage of whom
survived (ICNARC 2016; SICSAG). An ever-increasing number
of people, in the UK and globally, are surviving the ICU, and
short-term mortality for critical illnesses is decreasing in general
(Needham 2012). Despite this progress, ICU stay has been linked
with a number of physical and psychological sequelae that afflict
these survivors, potentially for years after critical illness. ICU fol-
low-up services are relatively recent developments in healthcare
systems, the purposes of which are to help address this wide vari-
ety of impairments by identifying and addressing patients’ health
needs directly or by providing access to additional healthcare ser-
vices.
Description of the condition
Critical illness, and the ICU stay itself, can be traumatic experi-
ences, which have been known to cause physical and psycholog-
ical distress that can extend far beyond the initial illness and any
short-term treatment. The long-term problems arising from the
ICU, known as ’post-intensive care syndrome’ (PICS), (Needham
2012), include mortality, post-traumatic stress disorder (PTSD),
anxiety, depression and physical impairments, and can also include
sexual dysfunction, amnesia of the ICUperiod, and various related
social problems (Griffiths 2007; Oeyen 2010). PICS not only af-
fects ICU survivors, but also amplifies the burden for their fami-
lies and dramatically increases costs for healthcare systems (Jones
1998; Needham 2011).
Mortality figures at one year after discharge range from 26% to
63%, and those for five years after discharge are reported to be
between 40% and 58% (Williams 2005).
The quality-of-life scores of ICU survivors are lower than aver-
age (for an age- and gender-matched population), and while re-
search shows that quality of life and basic functionality does be-
gin to slowly improve, this disparity compared with the general
population tends to remain for at least five years after discharge
(Cuthbertson 2005; Cuthbertson 2010; Eddleston 2000; Oeyen
2010), and may never fully return to pre-admittance levels (Van
der Schaaf 2009).
Additionally, between 19% to 22% of ICU survivors are affected
by PTSD up to 10 years after critical illness, and for survivors
of acute respiratory distress syndrome (ARDS) this figure could
be as high as 44% (Davydow 2008a; Davydow 2008b). Anxiety
may affect 23% to 48% of ARDS survivors up to 28 months
after illness. The incidence of depression in the same group ranges
from 17% to 43%, and this incidence may affect 8% to 57%
of the general ICU population at 14 months (Davydow 2008b;
Davydow 2008c).
Even with this research, there exist significant gaps in our knowl-
edge of post-ICU cognitive morbidities, and more attention may
need to be paid in particular to the impact of delirium and
prior health status, for example to include frailty (Bagshaw 2015;
Cuthbertson 2009; Needham 2012; NICE 2009; Pandharipande
2013).
Description of the intervention
For this review we define an ICU follow-up strategy as any ser-
vice set up to address specifically the various health needs of ICU
survivors, to prevent the development of physical, psychological
and social problems over the long term. There is, however, no one
acceptedmodel for such services (Rattray 2007). TheUKhas been
at the centre of research into critical care follow-up (Lasiter 2016;
Williams 2008), and there has been substantial investment in ICU
follow-up services, leading to a doubling of their number between
2002 and 2006 (Cuthbertson 2003; Griffiths 2006). Though the
first follow-up clinic in theUKwas set up in 1985 (Griffiths 2006),
and following official recommendations coming from the King’s
Fund Panel in 1989 (King’s Fund 1989), and the ‘Critical to Suc-
cess’ audit commission in 1999 (Audit Commission 1999), the
development of ICU follow-up clinics has been an ad hoc, exper-
imental process, not a systematic one (Angus 2003; Jensen 2015).
Today, still, there is no standardisation of such services across Na-
tional Health Service (NHS) trusts or other healthcare systems
globally.
Indeed, on a global level, ICU follow-up programmes have seen
mixed levels of attention and implementation. Recent initiatives
by the Institute of Medicine in the USA have resulted in greater
attention being paid to this important aspect of post-critical care
(Lasiter 2016), with systems such as the Indiana University School
of Medicine’s Critical Care Recovery Center (CCRC) being set
up (Khan 2015) and the THRIVE Peer Support Collaborative
(Society of Critical Care Medicine). In Scandinavian countries
(Norway, Denmark and Sweden), there is evidence of local initia-
tives dating back to the early 1990s. While UK services have em-
phasised physical rehabilitation (NICE 2009), the programmes in
the Scandinavian countries have tended to focus on patient-led
initiatives, including diaries and dialogue (Egerod 2013; Jensen
2015). There appears to be a lack of available data from other
countries, which is perhaps no surprise given the slow implemen-
tation even in more developed healthcare systems.
Types of services that may be offered to ICU survivors range from
informal interviews to more organised sessions. They may be pa-
tient-led and focus around the sharing of experiences, or led by
healthcare personnel with the purpose of providing information
to the patient; equally, they may be focused around physical re-
habilitation, or around addressing cognitive dysfunction (NICE
2009). Guidelines published by the National Institute for Health
and Care Excellence (NICE) recommended both that preventa-
tive measures should be started in the ICU setting and that mul-
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tidisciplinary functional assessments should be conducted by ap-
propriately trained personnel two to three months after ICU dis-
charge (NICE 2009). Importantly however, these guidelines ac-
knowledge the limitations of the current consensus surrounding
ICU follow-up (NICE 2009).
How the intervention might work
The general aims of a follow-up service in this review are to: pro-
vide a forum in which to identify and address any unmet health
needs; and to identify possible PICS, and allow for their further
management within or without the hospital setting. How such a
service might achieve these aims can vary widely, however. Follow-
up services may take the form of informal meetings that facilitate
a patient-led sharing of experiences that can provide reassurance
to the ICU survivor and potentially reduce depression or anxiety,
or they may involve access to standard general practitioner (GP)
services.
More organised sessions, which may either be nurse- or physician-
led, might involve discussion of specific physical or psychological
conditions and subsequent referral to appropriate health providers
to manage these conditions. A follow-up service might be con-
ducted face-to-face or by remote access. It might be assessed using
locally derived questionnaires, or through standardised question-
naires using validated scales. For complex interventions such as
this one, a preferred model may be one that is tailored to local
circumstances rather than being completely standardised (Craig
2008). Equally, the inherent heterogeneity of the patient popu-
lation within any single ICU might further complicate any stan-
dardisation of follow-up services. It has been suggested, for exam-
ple, that patients who have had a longer ICU stay, or who have had
incidents of delirium, may react to follow-up services differently.
So while it might be beneficial for clinics to target their resources
at those most likely to benefit (Aitken 2015; Cuthbertson 2009;
Jensen 2015), the lack of a thorough epidemiological study base
for these differences makes conclusions in this area speculative
(Needham 2012).
Globally, ICUs treat people with a large range of diseases and gen-
eral afflictions, and varying severities of conditions, patient back-
grounds and socioeconomic factors. It is feasible that follow-up
services may be more beneficial to particular patient groups. For
example, the socioeconomic conditions of an individual can af-
fect quality of life, cause or exacerbate anxiety and depression, and
affect physical function, and, in lower-income countries, mortal-
ity. Another important consideration, and one that has been over-
looked in much of the literature (Williams 2008), is that of ICU
access. Access to hospital-based follow-up services, which may be
relatively simple for UK-based patients, has the potential to be
extremely difficult for those living in very large tertiary care catch-
ment areas. This means that conclusions reached about these ser-
vices may not be relevant for clinicians and patients in rural areas
around the world.
Why it is important to do this review
Though there is a growing civil, scholarly, and governmental de-
sire for information on the role that ICU follow-up services might
play within an integrated recovery process, which starts in the ICU
and continues long afterwards, there has been, and still is, a lack
of medical consensus (Angus 2003; NICE 2009). In the UK, the
USA and around the world, ICU follow-up initiatives have not re-
ceived as much dedicated funding or widespread implementation
as those of oncology care, spinal injury care, or military veterans’
care (Needham 2012). ICU follow-up services appear intuitively
beneficial (Cuthbertson 2003; Rattray 2007), but it is still impor-
tant that they are grounded in the principles of evidence-based
medicine.
To date, there has been no Cochrane Review to assess the effective-
ness of ICU follow-up services as a general system of care.We have
identified a number of reviews dedicated to this subject (Jensen
2015; Niven 2014; Williams 2008). These reviews, among other
differences, either require updating (Williams 2008), or have dif-
ferent emphases (Jensen 2015; Niven 2014). Niven 2014, for ex-
ample, focuses on ICU transition services and the risk of read-
mission, whereas Jensen 2015 has subtle differences regarding in-
clusion criteria for studies. Jensen and colleagues only included
randomised studies. Our emphasis in this review will be on both
randomised and non-randomised studies and will be directed to-
wards services that are both delivered by a healthcare professional
and address unmet health needs related to the ICU period. This is
an area of clinical importance that warrants a systematic approach.
O B J E C T I V E S
Our main objective was to assess the effectiveness of follow-up
services for ICU survivors that aim to identify and address unmet
health needs related to the ICU period. We aimed to assess ef-
fectiveness in relation to health-related quality of life (HRQoL),
mortality, depression and anxiety, post-traumatic stress disorder
(PTSD), physical function, cognitive function, ability to return to
work or education and adverse effects.
Our secondary objectives were to examine different models of fol-
low-up services. We aimed to explore: the effectiveness of service
organisation (physician- versus nurse-led, face-to-face versus re-
mote, timing of follow-up service); differences related to country
(high-income versus low- and middle-income countries); and ef-
fect of delirium, which can subsequently affect cognitive function,
and the effect of follow-up services may differ for these partici-
pants.
M E T H O D S
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Criteria for considering studies for this review
Types of studies
We included randomised and non-randomised studies. We did
not find any controlled before-after studies (defined as those in
which observations are made before and after the implementation
of an intervention) or interrupted time series studies (studies that
use observations at multiple time points before and after an in-
tervention in order to detect significant change over time). We
included full-text studies; none were conference abstracts or un-
published data from grey literature searches. We did not exclude
studies based on outcomes or methods of analysis.
Types of participants
We included adults who had been discharged from hospital fol-
lowing a stay in an ICU that required level 3 care. We did not
exclude participants based on the reason they were admitted to
the ICU, so long as they were subject to level 3 care. We defined
level 3 care, or the equivalent grade in other healthcare systems,
as requiring advanced respiratory support, or care that required
the artificial support of at least two organs (Intensive Care Society
2009). We included participants who had been admitted to any
ICU, and planned to include admission to high-dependency or
critical care units or other hospital wards specifically designed to
cater for patients who were critically ill.
We excluded participants who were in any existing rehabilitation
programme, for example those associated with traumatic brain in-
jury, spinal cord injury, military trauma and cancer or cardiac care.
We did not exclude otherwise eligible patients based on location,
geographical dispersion, gender, or any other factor.
Types of interventions
We included studies that assessed a follow-up service (interven-
tion) attended by ICU survivors on at least one occasion com-
pared to either no follow-up service or standard care (control).
We defined a follow-up service as any consultation delivered by
a healthcare professional (such as a nurse or doctor) or an appro-
priately trained other person, which sought to specifically identify
or address unmet health needs directly related to the ICU period.
We included studies in which the service was conducted either
face-to-face or remotely (e.g. through email or telephone contact),
and at an appropriate location, such as a clinic or home visit. We
included services that started at any time within six months of
discharge from hospital. We included studies in which the follow-
up service sought to address needs through immediate support or
subsequent referrals.
We excluded studies that offered a follow-up service that only
provided general (non-ICU related) information or educational
materials to the participant, and we excluded studies that were
not delivered by a healthcare professional or appropriately trained
other person. We excluded studies of specialist services designed
to manage physical or psychological conditions, such as rehabil-
itation services. Although these services may address conditions
related to the ICU stay, for the purpose of this review we treated a
rehabilitation service as distinct from a follow-up service, in which
a consultation-style service aims to identify any type of unmet
need; participants may be referred to these specialist rehabilitation
services during a follow-up consultation. We excluded studies of
use of diaries kept during the ICU stay, which are given to partici-
pants at or after ICU discharge; this is reviewed elsewhere (Ullman
2014).
Standard care (control group), which may also be described by
study authors as usual care, included general practitioner (GP) vis-
its and care related to ongoing knownmedical conditions that were
not targeted at identifying and addressing unmet needs related to
the period spent in the ICU. For the purpose of this review, we
referred to ’usual care’ as ’standard care’. We anticipated that stan-
dard care may differ in each study because of differences in institu-
tion protocols and primary care services; for example, diagnosis of
some ICU-related symptoms (such as PTSD or anxiety) may also
be made during scheduled or unscheduled GP appointments. We
reported descriptions of standard care in each study during data
extraction and management.
Types of outcome measures
We assessed the effectiveness of follow-up services by measuring
differences in physical and psychological outcomes for study par-
ticipants. Our main outcome was an overall assessment of health-
related quality of life (HRQoL). We collected data from studies
that used a validated tool to assess HRQoL (Euroqol-5D (EQ-
5D)), and reported an overall mean value for study participants
from the validated tools; the EQ-5D scale assesses mobility, self-
care, main activity, family/leisure activity, pain/discomfort, anxi-
ety and depression (RAND). We collected data on the number of
deaths from any cause up to 12 months post-ICU. We reported
psychological outcomes in terms of anxiety or depression or both,
and collected these data from components of the above scales
or other validated tools, such as the Hospital Anxiety and De-
pression Scale for anxiety and depression (HADS-A and HADS-
D)(Zigmond 1983).
For post-traumatic stress disorder (PTSD), we used validated
scales reported by study authors: Davidson Trauma Scale (DTS)
(Davidson 2002); Harvard Trauma Questionnaire (HTQ) (
Mollica 1992); 10-item Post Traumatic Symptom Scale (PTSS-
10) (Raphael 1989) and Impact of Events Scale (IES) (Weiss
1996). These assessment scales use self-report measurements. We
reported physical function and cognitive function using the 36
item Short Form Survey (SF-36), or a simpler version of this tool
(SF-8). The SF-36 scale assesses the following: physical function-
ing, social functioning, role limitations, pain, mental health, vi-
tality, and general health perceptions (Brazier 1993). It has two
components (physical component (PCS), and mental component
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(MCS), which are appropriate to measure physical and cognitive
functioning. Data for the ability of participants to return to work
was collected as the percentage of people who have returned to
work at the follow-up time point.
We planned to collect data for adverse events. Examples of adverse
events included increased or continued dependency on medical
services rather than a transition into activities of daily living; poten-
tial exacerbation of symptoms, for example because of formalised
recollection of ICU experiences; or duplication or fragmentation
of medical services as noted by study investigators, for example
because the participant is offered access to an ICU physician-led
follow-up service alongside other rehabilitation services.
We collected data for all outcomes at the final time point measured
by study authors.
In summary, we collected data for the following outcomes:
Primary outcomes
1. Health-related quality of life (HRQoL)
2. All cause mortality
3. Depression and anxiety
Secondary outcomes
1. Post-traumatic stress disorder (PTSD)
2. Physical function
3. Cognitive function
4. Ability to return to work or education
5. Adverse effects
We included studies regardless of whether they reported data for
our review outcomes.
Search methods for identification of studies
Electronic searches
We searched the Cochrane Database of Systematic Reviews
(CDSR) and the Database of Abstracts of Reviews of Effects
(DARE) for primary studies included in related systematic reviews.
We searched the following databases on 7 November 2017:
1. Cochrane Central Register of Controlled Trials
(CENTRAL; 2017, Issue 11), in the Cochrane Library
2. MEDLINE Ovid (1985 to 7 November 2017)
3. Embase Ovid (1985 to 7 November 2017)
4. CINAHL EBSCO (1985 to 7 November 2017)
The Effective Practice and Organisation of Care (EPOC) Infor-
mation Specialist (IS) in consultation with the review authors de-
veloped the search strategies. Search strategies are comprised of
keywords and controlled vocabulary terms. We applied no lan-
guage or time limits. We searched all databases from database start
to date of search. See Appendix 1 for search strategies. We used a
PRISMA study flow diagram to report results of the search (Figure
1).
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Figure 1. Study flow diagram
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Searching other resources
Trials registries
We searched the following trials registers on 22 August 2017.
1. WHO ICTRP (World Health Organization International
Clinical Trials Registry Platform ( www.who.int/ictrp)
2. US National Institutes of Health Ongoing Trials Register,
ClinicalTrials.gov ( www.clinicaltrials.gov)
Grey literature
We conducted a grey literature search to identify studies not in-
dexed in the databases listed above. We searched the following
sources on 30 October 2017.
1. National Institute for Health and Clinical Excellence (
NICE) ( www.evidence.nhs.uk)
2. OpenGrey ( www.opengrey.eu)
We also reviewed reference lists of all included studies and relevant
systematic reviews (Jensen 2015; Lasiter 2016; Mehlhorn 2014;
Svenningsen 2017; Williams 2008), for additional, potentially el-
igible primary studies. We conducted forward citation reference
searches for all included studies in ISI Web of Science (Web of
Science Core Collection).
Data collection and analysis
Selection of studies
We downloaded all titles and abstracts retrieved by electronic
searching to a referencemanagement database and removed dupli-
cates. Oliver Schofield-Robinson (OSR) and Sharon Lewis (SL)
independently screened all titles and abstracts and removed studies
that were very unlikely to be eligible. If no abstract was available
but the title was possibly relevant, we obtained the full text of the
article. We independently reviewed the full text of potentially rel-
evant titles using the criteria for studies (Criteria for considering
studies for this review). We resolved any disagreement through
discussion and by consultation with a third review author, Phil
Alderson (PA). We collated multiple reports of the same study so
that each study rather than each report was the unit of interest in
the review. We used Covidence software (Covidence) to manage
selection of studies.
Data extraction and management
For data extraction and management for all study designs, we
used Covidence software (Covidence). We created a template in
Covidence using an adapted standard EPOC data collection form
(EPOC 2013a), for study characteristics and outcome data; we pi-
loted this form on one included study. Two review authors (OSR
and SL) independently extracted the following study characteris-
tics from the included studies.
1. Methods: study design, number of study centres and
location, study setting, date of study
2. Participants: number, mean age, age range, ethnicity,
gender, socioeconomic descriptions (e.g. economic status,
education and employment status), APACHE II score, presence
of ARDS, reason for ICU stay, episodes of delirium whilst in the
ICU (CAM-ICU score; Ely 2001), withdrawals, diagnostic
criteria, length of stay in the ICU, duration of sedation,
inclusion criteria, exclusion criteria, other relevant characteristics
3. Interventions: intervention components, comparison
(control group: standard care or no follow-up service)
components, direct or remote clinic, materials involved, time
point of intervention, time point of follow-up, physician- or
nurse-led, number of attended clinics, number of participants
per clinic
4. Outcomes: main and other outcomes specified and
collected, time points reported
5. Notes: funding for study, notable conflicts of interest of
study authors, ethical approval
We resolved disagreements by consensus or by consultation with
a third review author (PA).
Assessment of risk of bias in included studies
Two review authors (SL and OSR) independently assessed risk
of bias for each study using the criteria outlined in the Cochrane
Handbook for Systematic Reviews of Interventions (Higgins 2017),
and guidance from Cochrane EPOC. For randomised and non-
randomised studies we assessed the following criteria (EPOC
2009).
1. Was the allocation sequence adequately generated?
2. Was the allocation adequately concealed?
3. Were baseline outcome measurements similar?
4. Were baseline characteristics similar?
5. Were incomplete outcome data adequately addressed?
6. Was knowledge of the allocated interventions adequately
prevented during the study?
7. Was the study adequately protected against contamination?
8. Was the study free from selective outcome reporting?
9. Was the study free from other risks of bias?
We judged each potential source of bias as high, low, or unclear
and provided a justification for our judgment in the ’Risk of bias’
table. We summarised ’Risk of bias’ judgements across different
studies for each of the domains listed.
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We did not exclude studies on the grounds of their risk of bias.
We used the EPOC ’Risk of bias’ guidance information to help
reach our judgements (EPOC2009).We used Covidence software
(Covidence), to record ’Risk of bias’ decisions; see Appendix 2
for a draft of the ’Risk of bias’ table that we modified for use in
Covidence.
Assessment of bias in conducting the systematic
review
We conducted the review according to our published protocol (
Schofield-Robinson 2017), and have reported any deviations from
it in Differences between protocol and review.
Measures of treatment effect
For randomised and non-randomised studies, we collected con-
tinuous data from validated scales (for: HRQoL, depression and
anxiety, PTSD, physical function, cognitive function), as reported
by study authors at the end of follow-up time point. We collected
these data as mean scores; if mean scores were not available we col-
lected effect estimates reported by study authors (whichwere: stan-
dardised mean difference (SMD), and absolute risk reductions),
or median scores. We collected dichotomous data for mortality
and the number of participants who were able to return to work
at the end of follow-up.
None of the included studies presented data in graphs or figures, so
we did not need to reanalyse any data. We did not include studies
in meta-analysis in which data were not suitable for pooling.
Unit of analysis issues
We noted no unit of analysis issues in any studies.
Dealing with missing data
We did not contact investigators to verify missing study charac-
teristics; we used data as presented in each published version of
the studies. We used available data published by study authors,
using intention-to-treat data when reported. We did not impute
missing data with replacement values in this review.
Assessment of heterogeneity
We assessed clinical and methodological heterogeneity by consid-
eration of study design, participants and how the follow-up clinics
were conducted. Differences, for example, in the socioeconomic
background of the participants, has the potential to influence out-
come data, and substantial heterogeneity warranted decisions not
to pool data. We assessed statistical heterogeneity using the Chi²
statistic and related P value, or the I² statistic with associated per-
centage values (Higgins 2003), for outcomes in which it was pos-
sible to combine study data. We used the following cut-offs as a
guide to interpretation: I² statistic at 0% to 40% is not considered
important, 30% to 60% suggests moderate heterogeneity, 50% to
90% suggests substantial heterogeneity, and 75% to 100% is con-
siderable heterogeneity (Deeks 2017). If we identified substantial
clinical, methodological or statistical heterogeneity we planned to
explore it by prespecified subgroup analysis.
We expected heterogeneity in our included study designs to derive
from:
1. type of follow-up clinic used (e.g. nurse-led or physician-
led; face-to-face or remote);
2. time points of clinics;
3. time points of outcome assessment;
4. potential risk of developing long-term symptoms relating to
the ICU stay; and
5. socioeconomic conditions of participant.
Certain conditions may increase the likelihood of long-term psy-
chological symptoms for ICU survivors, for example, people with
acute respiratory distress syndrome (ARDS) who survive the ICU
may be at a higher risk of developing depression, anxiety and
PTSD (Davydow 2008b). We assessed heterogeneity by consider-
ation of differences in baseline data between studies, for example
in: presence of ARDS, length of ICU stay, length of sedation, and
APACHE II and SAPS II scores.
Assessment of reporting biases
We used data as presented in each published version of the studies;
we did not contact investigators to verify missing outcome data.
We assessed the risk of reporting bias using the Cochrane ’Risk
of bias’ tool; we searched for prospective clinical trials registration
documents for included studies to use in our assessment of risk of
reporting bias. We were unable to explore the risk of publication
bias through examination of funnel plots (Sterne 2011), because
we identified fewer than 10 studies in the review (Sterne 2017).
Data synthesis
We conducted meta-analysis only where this was meaningful, that
is, if the treatments, participants, and the underlying clinical ques-
tion were similar enough for pooling to make sense. We noted
scales used to measure continuous outcomes. We combined data
if scales were the same and data were suitable for pooling. If scales
were different but were sufficiently similar (and direction of effect
was the same), we combined data using generic inverse variance to
account for anticipated differences in the scales, study populations,
and interventions (Deeks 2017). When study authors reported
measurement scales, we presented direction of the effect for these
scales in order to make meaningful interpretation of differences
between groups. A common way that investigators indicate when
they have skewed data is by reporting medians and interquartile
ranges. When we encountered this, we noted that the data may be
skewed.
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For dichotomous data, we used risk ratios (RR) with 95% CI, us-
ing Mantel-Haenszel. We used a random-effects model for meta-
analysis, which accounts for possible differences between studies
in which participant conditions may vary and type of follow-up
service designmay vary.We conductedmeta-analysis using the Re-
view Manager 5 (RevMan 5) calculator (Review Manager 2014).
If it was not possible to meta-analyse the data we summarised the
results in the text.
We reported in the Characteristics of included studies whether
study authors had used adjusted or unadjusted data in analysis of
effect estimates, including factors that they had adjusted for. If
we did not combine mean scores in analysis, we reported adjusted
effect estimates of single studies in an additional table.
GRADE and ’Summary of findings’ table
We summarised the findings of themain intervention comparison
for all the outcomes (HRQoL, mortality, depression and anxiety,
PTSD, physical and cognitive function, time (ability) to return to
work or education, and adverse effects) in a ’Summary of findings’
table. This table enabled us to draw conclusions about the certainty
of the evidence within the text of the review. Two review authors
(OSR and SL) independently assessed the certainty of the evidence
(high,moderate, low, and very low), using the fiveGRADEconsid-
erations (study design, consistency of effect, imprecision, indirect-
ness, and publication bias; Guyatt 2008). We used methods and
recommendations described in Section 8.5 (Higgins 2017), and
Chapters 11 (Schünemann 2017), of the Cochrane Handbook for
Systematic Reviews of Intervention, the EPOC worksheets (EPOC
2013b), and GRADEpro software (GRADEpro GDT 2015). We
resolved disagreements on certainty ratings by discussion and pro-
vided justification for decisions to downgrade the certainty of the
evidence using footnotes in the table. We made comments to aid
readers’ understanding of the review where necessary. We used
plain language statements to report these findings in the review.
Subgroup analysis and investigation of heterogeneity
We did not conduct statistical subgroup analyses because we had
insufficient studies (we did not have more than 10 studies; Deeks
2017). We described differences between studies using two dis-
tinct categories (particular patient groups, and style of service), for
subgroups that we defined a priori, as follows.
1. Physician-led clinic versus nurse-led clinic
2. Face-to-face clinic versus remote clinic
3. Participants from low- and middle-income countries versus
participants from high-income countries (according to World
Development Index (WDI), (World Bank 2016))
4. Intervention conducted earlier than three months post-ICU
versus three to six months
5. Experienced ICU delirium versus no delirium
Subgroup analysis aimed to assess whether certain follow-up ser-
vices have disproportionate benefit for different groups. Organi-
sation, style and timing of follow-up services between studies may
introduce heterogeneity (Williams 2008), and some of these dif-
ferences may be explained by socioeconomic factors according to
the country of the study or inequity in access to healthcare ser-
vices, or both. For example, current UK guidelines recommend
face-to-face ICU follow-up at two to three months post-ICU dis-
charge (NICE 2009), which may be achievable in a developed
health economy but not in a low- or middle-income country. An
important socioeconomic consideration is the influence specifi-
cally of a nation’s status as a low-income or high-income economy,
which can impinge upon its citizens’ access to healthcare services.
To this end, we will assess country of study according to the WDI
(World Bank 2016). Delirium in the ICU and resultant cognitive
dysfunction, which has been shown to be a prevalent affliction
among the ICU survivor population and can affect quality of life
(Gordon 2004), also have the potential to contribute to clinical
heterogeneity. Such subgroup analyses might aid more precise tar-
geting of resources in future studies.
We collected data during the Data extraction and management
stage of the review to decide the subgroup for each study.
Sensitivity analysis
We did not perform sensitivity analyses because of the nature of
included studies in this review. We did not include unpublished
studies; no studies were at low risk of bias, and we did not use
imputed data.
R E S U L T S
Description of studies
Results of the search
We screened 13,457 titles and abstracts from database searches,
clinical trials register searches, grey literature, and forward and
backward citation searches. We carried out full-text review of 126
records, and reported details of 36 studies (with 45 records). We
identified five eligible studies (with 10 records), and five ongoing
studies. See Figure 1.
Included studies
We included five studies (with 10 records) with 1707 partici-
pants (Cuthbertson 2009; Douglas 2007; Jensen 2016; Schandl
2012; Schmidt 2016). Four studies were randomised studies
(Cuthbertson 2009; Douglas 2007; Jensen 2016; Schmidt 2016)
and one was a non-randomised study, with a before-after study
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design (Schandl 2012). All five studies employed a parallel-study
design. See Characteristics of included studies.
Study population and setting
All studies were in countries with advanced industrial economies.
Two were single-centre studies (Douglas 2007; Schandl 2012) and
three were multicentre studies (three centres: Cuthbertson 2009;
10 centres: Jensen 2016; nine centres: Schmidt 2016).
Included studies enrolled adult participants who were admitted to
and were expected to survive the intensive care unit (ICU); one
study enrolled participants who were at least 16 years of age but we
determined from the mean age at baseline that most participants
in this study were likely to be more than 18 years of age (Schandl
2012). Conditions of participants were varied but typical of ICU
admission, and included participants with either medical, surgical
and infective conditions, or injuries related to trauma.
Three studies used the Acute Physiology andChronicHealth Eval-
uation II scoring system (APACHE II) to report baseline severity
of participant illness (Cuthbertson 2009; Jensen 2016; Schandl
2012), and one study used APACHE III for this purpose (Douglas
2007). This scoring system can be used to predict patient mortal-
ity (Knaus 1985), and whilst we noted some variation in the range
of scores between Jensen 2016 and those in Cuthbertson 2009
and Schandl 2012, in general we found that these scores were in
a typical range for people in the ICU.
Although we acknowledge that length of stay may not be a direct
indicator of illness severity, for example some institutions may
have capacity to move patients more swiftly from the ICU to an
alternative high-dependency unit, we noted wide differences in
mean or median lengths of stay between studies. Schmidt 2016
reported the longest stay in the ICU amongst included studies,
with a mean stay in the control group of 35.2 (standard deviation
(SD) ± 26.7) days, whilst Cuthbertson 2009 reported the shortest
length of stay amongst included studies with median stays of 2.9
(interquartile range 1.7 to 9.5) days in the intervention group and
3.1 (interquartile range 1.2 to 7.5) days in the control group.
Interventions and comparators
Follow-up services were led by nurses or multidisciplinary teams
and included face-to-face consultations, telephone consultations
or both. Each study included at least one consultation (weekly,
monthly, or six-monthly) and two studies had up to eight consul-
tations.
Follow-up services were led by nurses in four studies (Cuthbertson
2009; Douglas 2007; Jensen 2016; Schmidt 2016), and in one
study by a multi-disciplinary team, which included nurses, physi-
cians, and physiotherapists (Schandl 2012). Participants attended
a clinic in two studies (on two occasions: Cuthbertson 2009; on
one occasion: Jensen 2016), and from the description in a third
study we assumed that the follow-up service was also in a clinic
setting (on three occasions: Schandl 2012). In Jensen 2016, par-
ticipants received two subsequent telephone consultations. One
study assessed a follow-up service with a minimum of eight visits
to the participant’s home or the extended care facility at which the
participant was staying (Douglas 2007), and in one study partici-
pants received monthly telephone consultations (Schmidt 2016).
Although each study described a different process bywhich the fol-
low-up service was conducted, in each study we noted that health-
care personnel carried out reviews and discussions with partici-
pants that included assessments and monitoring of participants’
needs. All studies referred participants to other specialist support if
necessary. One study involved construction of an illness narrative,
with dialogue aided by photographs and use of reflective sheets,
which required completion of pre-set sentences (e.g. “What I want
most is...”) (Jensen 2016).
Comparison groups in each study received standard care as di-
rected by each institution; standard care did not involve a follow-
up service.
Reported outcomes
All included studies reported reviewoutcomes, whichwere: health-
related quality of life (HRQoL), (Cuthbertson 2009; Douglas
2007; Jensen 2016; Schmidt 2016);mortality (Cuthbertson 2009;
Douglas 2007; Jensen 2016; Schandl 2012; Schmidt 2016); de-
pression and anxiety (Cuthbertson 2009; Jensen 2016; Schandl
2012); post-traumatic stress disorder (PTSD), (Cuthbertson
2009; Jensen 2016; Schandl 2012); physical and cognitive func-
tion (Cuthbertson 2009; Douglas 2007; Jensen 2016; Schmidt
2016); and ability to return towork (Cuthbertson 2009).No stud-
ies reported adverse effects.
Times of assessments were: at six and 12 months post-ICU dis-
charge (Cuthbertson 2009); at two months post-ICU discharge
(Douglas 2007) at three and 12 months post-ICU discharge
(Jensen 2016); at 14 months post-ICU discharge (Schandl 2012);
and at six and 12 months post-ICU discharge (Schmidt 2016).
We reported outcome data at the final time point in each study.
Funding sources
All studies received independent or department funding, which
we believed represented no apparent source of conflict in study
preparation and interpretation of results.
Excluded studies
We assessed 126 records for full-text eligibility. We excluded 81 of
these because they did not meet our review criteria; we have not
included details of these in the review.
We excluded 20 studies (with 24 records) that compared an inter-
vention that did notmeet our definitionof a follow-up clinic: seven
studies provided educational materials to ICU patients (Alberto
2011; IRCT201110197844N1; Jones 2003; NCT00976807;
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NCT02415634; Shaw 2012; Strahan 2003); two studies com-
pared a rehabilitation service (Jackson 2012; Walsh 2015); seven
studies compared use of a diary given to participants after an ICU
stay (Backman 2010; Garrouste-Orgeas 2010;Huynh 2017; Jones
2010; Knowles 2009; NCT02067559; Robson 2008); three stud-
ies compared a psychotherapy intervention (Cox 2014; Holmes
2007; ISRCTN97280643); and one study provided training to
participants (Cox 2017). We excluded two studies that did not
recruit ICU patients (ward-based participants: Ball 2003; coro-
nary care unit participants: Farazmand 2017). Following unsuc-
cessful attempts to contact study authors, we excluded four studies
that were published only as abstracts (Bourseau 2016; Cave 2016;
Davidson 2015; Ramnarain 2015); we will include these in future
review updates pending publication of full texts and assessment of
eligibility. See Characteristics of excluded studies.
Ongoing studies
We identified five eligible ongoing studies; four of which
were identified through clinical trials database searching (
ACTRN12616000206426; NCT01796509; NCT02077244;
NCT03124342), and one through primary database searching
(Paratz 2014). All are randomised studies and aim to recruit adult
participants who have been in the intensive care unit. Two stud-
ies specifically aim to recruit participants with diabetes mellitis
(ACTRN12616000206426) and with sepsis (Paratz 2014). On-
going studies aim to recruit 1684 participants. See Characteristics
of ongoing studies.
Risk of bias in included studies
See Characteristics of included studies and see ’Risk of bias’ sum-
mary and ’Risk of bias’ graph (Figure 2; Figure 3).
Figure 2. ’Risk of bias’ graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies
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Figure 3. ’Risk of bias’ summary: review authors’ judgements about each risk of bias item for each included
study
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Allocation
Four studies reported that participants were randomised (
Cuthbertson 2009; Douglas 2007; Jensen 2016; Schmidt 2016).
Two studies provided sufficient detail of randomisation methods
and we judged these studies to have a low risk of bias for sequence
generation (Cuthbertson 2009; Schmidt 2016). We judged two
studies to have unclear risk of sequence generation bias because
information on randomisation methods was insufficient (Douglas
2007; Jensen 2016).
Three studies reported no methods for allocation concealment
and we judged these to have an unclear risk of selection bias
(Cuthbertson 2009; Douglas 2007; Schmidt 2016). One study
described sealed, opaque envelopes in which to conceal the alloca-
tion, and we judged this to have low risk of selection bias (Jensen
2016).
One study was a non-randomised study (Schandl 2012). This
study design introduces a high risk of bias because participants are
not divided into groups using a random method, and personnel
would have known the allocation.
Blinding
This intervention precluded the possibility of blinding of partic-
ipants and personnel. We could not be certain whether perfor-
mance may have been influenced by knowledge of the interven-
tion (i.e. those that were receiving a follow-up service); we judged
all studies to have an unclear risk of performance bias.
Each study measured outcomes using participant self-assessments
(e.g. completion of questionnaires) and, although questionnaires
were validated and appropriate for their purpose, we could not
be certain whether knowledge of receiving the intervention would
influence self-assessments.We judged all studies to have an unclear
risk of detection bias.
Incomplete outcome data
All studies reported a high number of participant losses, in excess
of 10% of the patient populations. However, a high number of
participant losses are expected in studies with long follow-up pe-
riods (Cuthbertson 2005; Oeyen 2010; Williams 2011). Loss of
participants in each study was balanced between groups and we
judged all studies to have an unclear risk of attrition bias.
Selective reporting
Three studies reported registration with clinical trials registers (
Cuthbertson 2009; Jensen 2016; Schmidt 2016). Registration was
retrospective in Cuthbertson 2009 and Schmidt 2016, and it was
not feasible to use these documents to assess the risk of selective
outcome reporting. Jensen 2016 reported prospective registration,
and using these documents we judged this study to have a low risk
of selective outcome reporting bias. Two studies did not report
registration with clinical trials registers and we judged these studies
to have unclear risk of selective outcome reporting bias (Douglas
2007; Schandl 2012).
Protection against contamination
In all studies, a procedure for the follow-up service was adhered
to, and healthcare professionals were used to carry out the inter-
vention. We judged the risk of contamination of the control group
to be low across randomised studies (Cuthbertson 2009; Douglas
2007; Jensen 2016; Schmidt 2016). Because of the time difference
between the control group and the intervention group in the non-
randomised study, we could not be certain that other variables in
service delivery were equivalent over time and we judged this study
to have high risk of bias for this domain (Schandl 2012).
Baseline characteristics
We judged the baseline characteristics between groups to be com-
parable in two studies andwe judged these to have a low risk of bias
for baseline characteristics (Jensen 2016; Schmidt 2016). Because
of a possible reporting error in Cuthbertson 2009, we judged this
study to have an unclear risk of bias for baseline characteristics;
we could not be certain whether the range of ages was equivalent
between groups.
We judged two studies to have high risk of bias for baseline char-
acteristics (Douglas 2007; Schandl 2012). In one study, we noted
an imbalance in severity of illness scores and HRQoL (Douglas
2007). The non-randomised study only reported baseline charac-
teristics for participants who received a questionnaire at 14months
(losses up to this stage could mostly be explained by participant
death), and we could not ascertain whether baseline characteristics
were equivalent for all participants included in the study (Schandl
2012). Also in Schandl 2012, we noted differences in these base-
line characteristics; more women in the control had had previous
psychological problems and we noted differences in length of ICU
stay, duration of sedation and types of diagnoses.
Other potential sources of bias
We noted no additional sources of bias in three studies (Jensen
2016; Schandl 2012; Schmidt 2016).
We judged two studies to have an additional high risk of bias
(Cuthbertson 2009; Douglas 2007). In Cuthbertson 2009, par-
ticipants in the intervention group also received a manual-based
physiotherapy programme and it is possible that this programme
could have influenced the outcome data rather than subsequent
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attendance at follow-up clinics. In Douglas 2007, we noted that
participants and family members in the intervention group were
involved in preparation of a discharge summary plan, and it is pos-
sible that preparing a discharge summary plan could have influ-
enced outcome data rather than subsequent attendance at follow-
up clinics.
Effects of interventions
See: Summary of findings for themain comparison ICU follow-
up services compared with standard care or no follow-up service
for survivors of critical illness
See Summary of findings for the main comparison, and Appendix
3.
Primary outcomes
1. Health-related quality of life (HRQoL)
Results from one study (286 randomised participants;
Cuthbertson 2009) suggest that a follow-up service may make
little or no difference to HRQoL at 12 months. This study re-
ported HRQoL as a composite measure using Euroqol-5D (EQ-
5D); lower scores on this scale indicate better HRQoL. Study au-
thors reported little or no difference in quality of life scores at 12
months (standardised mean difference (SMD) -0.0, 95% confi-
dence interval (CI) -0.1 to 0.1; P = 0.57; low-certainty evidence;
downgraded by one level for study limitations and one level for
imprecision). We have reported mean scores as reported by study
authors in Table 1.
2. All-cause mortality
Five studies (1707 participants) reported data for mortality
(Cuthbertson 2009; Douglas 2007; Jensen 2016; Schandl 2012;
Schmidt 2016).We combined four randomised studies (1297 ran-
domised participants) for mortality at end of follow-up (2 months
in: Douglas 2007; and 12 months in: Cuthbertson 2009; Jensen
2016; Schmidt 2016). Using a follow-up clinic probably makes
little or no difference to mortality up to 12 months after ICU dis-
charge (risk ratio (RR) 0.96, 95% confidence interval (CI) 0.76
to 1.22; 1289 analysed participants; moderate-certainty evidence;
downgraded one level for inconsistency). See Analysis 1.1.
One non-randomised study reported number of participants who
died before study follow-up at 14 months as part of the study flow
diagram (Schandl 2012). Study authors did not report analysis of
this data, and reported 79 deaths in the intervention (of 259 par-
ticipants) and 46 deaths in the control group (of 151 participants).
3. Depression and Anxiety
Three studies (1082 participants) reported data for depression and
anxiety using the Hospital Anxiety and Depression scale (HADS)
(Cuthbertson 2009; Jensen 2016; Schandl 2012); lower scores
indicate less depression and less anxiety on each scale.
We were unable to combine data for two randomised studies (672
randomised participants; Cuthbertson 2009; Jensen 2016), be-
cause study authors in Jensen 2016 did not report data in a format
suitable for pooling. Both study authors reported little or no dif-
ference in HADS scores for depression (HADS-D) at 12 months
between participants who received a follow-up service after ICU
discharge and those who received no follow-up service (SMD -
0.1, 95% CI -1.2 to 1.0, P = 0.86 in Cuthbertson 2009; abso-
lute risk reduction (usual care vs intervention) -0.20, 95% CI -
1.12 to 0.72, P = 0.67 in Jensen 2016). One non-randomised
study (410 participants) reported little or no difference in HADS-
D scores between participants who received a follow-up service
after ICU discharge and participants who received no follow-up
service (women: P = 0.09; men: P = 0.47). We have included data
reported by study authors in Table 1, and we noted that Schandl
2012 reported median scores, which suggests that data may be
skewed.
Study authors also reported little or no difference in HADS scores
for anxiety (HADS-A) at 12 months between participants who
received a follow-up service after ICU discharge and participants
who received no follow-up service (SMD -0.8, 95%CI -1.9 to 0.4,
P = 0.18 in Cuthbertson 2009; absolute risk reduction (usual care
vs intervention) -0.21, 95% CI -1.22 to 0.80, P = 0.68 in Jensen
2016). We have included data as reported by study authors in
Table 1. One non-randomised study (410 participants) reported
little or no difference in HADS-A scores (women: P = 0.14; men:
P = 0.78) (Schandl 2012). We have included data reported by
study authors inTable 1, andwe noted that Schandl 2012 reported
median scores, which suggests that data may be skewed.
It is uncertain whether using a follow-up service reduces depres-
sion and anxiety because the certainty of this evidence is very low
(we downgraded by one level for study limitations, one level for
inconsistency, and one level for imprecision).
Secondary outcomes
1. Post-traumatic stress disorder (PTSD)
Four studies (1082 participants) reported PTSD (Cuthbertson
2009; Jensen 2016; Schandl 2012; Schmidt 2016). Scales used
were the Davidson Trauma Scale (DTS) (Cuthbertson 2009), the
HarvardTraumaQuestionnaire Part IV (HTQ-IV) (Jensen 2016),
Impact of Events Scale (IES) (Schandl 2012), and the 10-item
Post Traumatic Symptom Scale (PTSS-10) (Schmidt 2016).
We combined data at 12 months in Cuthbertson 2009, Jensen
2016, and Schmidt 2016 using inverse variance to account for
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differences in measurement tools. We found little or no difference
in PTSDbetween those who received a follow-up service and those
who did not (SMD -0.05, 95%CI -0.19 to 0.10; 703 participants;
3 studies; low-certainty evidence; downgraded one level for study
limitations and one level for inconsistency). See Analysis 1.4.
Schandl 2012 used the Impact of Events scale (IES) at 14 months;
lower scores indicate less chance of PTSD. Study authors reported
that female participants who received a follow-up service had a
lower score (P = 0.01), which indicated a reduced chance of having
PTSD; study authors reported no difference in scores between
groups for male participants (P = 0.27). We have included data as
reported by study authors in Table 1.
2. Physical function
Four randomised studies (1297 participants) reported physical
functioning using the physical component score (PCS) of SF-
36 (Cuthbertson 2009; Jensen 2016; Schmidt 2016), and SF-8
(Douglas 2007); higher scores indicate less impairment.
Jensen 2016 reported mean and mean difference scores, and we
used the calculator in Review Manager 2014 to calculate SDs for
each group. We combined data for two randomised studies and
found little or no difference in physical function scores between
participants who received a follow-up service after ICU discharge
and those who received no follow-up service (MD 1.31, 95% CI
-0.86 to 3.49; 422 participants). See Analysis 1.2.
We could not combine data for Douglas 2007 and Schmidt 2016
because study authors did not report data as mean (SD) and we
could not calculate this from the data in the study reports.
In Douglas 2007, study authors reported little or no difference in
physical scores at two months after ICU discharge once baseline
scores and APACHE III scores were controlled for (P = 0.40).
However, study authors also reported re-analysis of these results,
accounting for loss of participants because of death. In this analy-
sis, study authors reported that more participants who received a
follow-up service had improved physical HRQoL (P = 0.02).
In Schmidt 2016, study authors reported little or no difference in
physical HRQoL at 12 months between participants who received
a follow-up service after ICU discharge and those who received no
follow-up service (P > 0.05).
It is uncertain whether using a follow-up service improves physical
function because the certainty of this evidence is very low. We
downgraded by one level for study limitations and by two levels
for inconsistency.
3. Cognitive function
Four randomised studies (1297 participants) reported cognitive
functioning using the mental component score (MCS) of SF-36
(in: Cuthbertson 2009; Jensen 2016; Schmidt 2016) and SF-8
(Douglas 2007); higher scores indicate less impairment.
Jensen 2016 and Schmidt 2016 reported mean and mean differ-
ence scores, and we used the calculator in Review Manager 2014
to calculate SDs for each group in each study. We found some
differences in calculations that may be explained by study authors
who reported that, “due to rounding, change scores may not add
up precisely”. We combined data for three studies and found little
or no difference in MCS scores between participants who received
a follow-up service after ICU discharge and those who received no
follow-up service (MD 1.44, 95% CI -0.51 to 3.39; 622 analysed
participants). See Analysis 1.3.
We did not include data for Douglas 2007 in analysis because
study authors did not report data as mean (SD) and we could
not calculate this from the data in study reports. Study authors
reported re-analysis of results accounting for loss of participants
because of death; in this analysis study authors reported no differ-
ence in cognitive function scores at two months between partic-
ipants who received a follow-up service after ICU discharge and
those who received no follow-up service (study authors did not
report P values).
It is uncertain whether using a follow-up service improves physical
function because the certainty of this evidence is very low. We
downgraded by one level for study limitations and by two levels
for inconsistency.
4. Ability to return to work
One randomised study reported number of participants who re-
turned to work at 12 months (Cuthbertson 2009; 286 partici-
pants). Study authors reported little or no difference between par-
ticipants who received a follow-up service after ICU discharge and
those who received no follow-up service in the number of partici-
pants who returned to work. We included data reported by study
authors in Table 1.
It is uncertain whether using a follow-up service improves the
ability to return to work because the certainty of this evidence is
very low. We downgraded by one level for study limitations and
by two levels for imprecision.
5. Adverse effects
No studies reported adverse events.
Subgroup analysis
We found insufficient studies for subgroup analyses. We narra-
tively reported differences between studies following our planned
subgroups.
1. Physician-led clinic versus nurse-led clinic: four studies
used a follow-up service that was nurse-led (Cuthbertson 2009;
Douglas 2007; Jensen 2016; Schmidt 2016). One study
included a multi-disciplinary team, which included nurses,
physicians, and physiotherapists (Schandl 2012).
2. Face-to-face clinic versus remote clinic: three studies used a
face-to-face clinic (Cuthbertson 2009; Douglas 2007; Schandl
2012). Jensen 2016 incorporated both face-to-face and
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telephone contact with participants, and Schmidt 2016 used
telephone contact with participants.
3. Participants from low- and middle-income countries versus
participants from high-income countries (according to World
Development Index (WDI) (World Bank 2016)): all included
studies took place in high-income countries and we could not
perform subgroup analysis for this.
4. Intervention conducted earlier than three months post-ICU
versus three to six months: one study conducted a follow-up
service only within three months of ICU discharge (Douglas
2007). Two studies conducted follow-up services that began at
three months post-ICU discharge (Cuthbertson 2009; Schandl
2012). Two studies conducted follow-up services that began
earlier than three months post-ICU discharge and continued
after three months post-ICU discharge (Jensen 2016; Schmidt
2016).
5. Experience of ICU delirium versus no delirium: three
studies did not report whether participants experienced delirium
(Cuthbertson 2009; Douglas 2007; Schandl 2012). One study
excluded participants with cognitive deficits and we assumed
that included participants in this study did not have delirium
(Schmidt 2016). One study reported median number of days of
delirium at baseline for participants who had been assessed for
delirium (Jensen 2016).
Sensitivity analysis
1. Restricting the analysis to published studies: we used only
data from published studies and could not perform sensitivity
analysis for this.
2. Restricting the analysis to studies with a low risk of
selection bias: we found no studies that we judged to have a low
risk of selection bias for both random sequence generation and
allocation concealment, and therefore we could not perform
sensitivity analysis for this.
3. Using available case data or using imputed data (from last
observation carried forward) where studies had missing data: we
used data reported by study authors, and when available we used
intention-to-treat analysis as reported by study authors. We did
not impute any study data in this review.
D I S C U S S I O N
Summary of main results
We included five studies comparing a follow-up service provided
to survivors of the intensive care unit (ICU) versus standard care,
which had no follow-up service; four studies were randomised
studies and one was a non-randomised study. We also identified
five ongoing studies.
In summary, we found little or no difference for each of our out-
comes between participants who received a follow-up service and
participants who received standard care. We found low-certainty
evidence from one randomised study that a follow-up service may
make little or no difference to HRQoL at 12 months after ICU
discharge and moderate-certainty evidence from meta-analysis of
four randomised studies that a follow-up service may make little
or no difference in the number of participants who die up to 12
months after ICU discharge (one non-randomised study reported
mortality in each group but we did not analyse this). Evidence
for depression and anxiety from two randomised studies and one
non-randomised study was very low-certainty.
We found that a follow-up service may make little or no difference
to PTSD (low-certainty evidence from three randomised studies);
one non-randomised study reported that women had less chance
of having PTSD. Our evidence for physical and cognitive function
was from four randomised studies, and for ability to return to
work was from one study; we could not be certain whether follow-
up services had an effect on these outcomes because evidence was
very low certainty. No study reported adverse effects.
Overall completeness and applicability of
evidence
We identified five studies including 1707 participants who sur-
vived their stay in the ICU after having been admitted for a variety
of reasons.
We noted differences between studies in participant diagnoses,
ranges of prognostic scores (using APACHE II and APACHE III),
and durations of ICU stay, and one study included only partici-
pants who had severe sepsis or septic shock. However, all studies
included participants that had conditions typical of the general
ICU population, and whilst we noted the same conditions in some
studies (e.g. cardiovascular or neurological conditions), we were
unable to clarify whether all conditions were comparable between
all studies. We noted that three studies included some participants
who had injuries related to trauma and it is possible that these
participants may have had additional psychological difficulties re-
lated to their injury (for example PTSD), rather than the ICU stay
(Cuthbertson 2009; Jensen 2016; Schandl 2012). In this review
we did not explore whether outcome data may be affected by type
of condition that ICU survivors had experienced. Included stud-
ies were conducted between 2001 and 2015, and were likely to
represent more recent ICU patient management.
All studies were conducted in high-income countries and any re-
sults are applicable only to these countries, in which healthcare
resources are more likely to be comparable.
We anticipated a variety of types of follow-up services and this was
evident from our included studies. All studies provided a follow-
up service with a nurse and only one study included other health-
care professionals. However, types of service (face-to-face or via
telephone; in a clinic setting or at home) differed between studies
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and participants received a different number of consultations (up
to eight consultations in total) and the time between consultations
also differed (weekly, monthly, or up to six months apart).
We were unable to conduct subgroup analysis because we found
insufficient studies, and therefore it was not possible to apply our
results to any single design of follow-up service.
Certainty of the evidence
Few studies reported sufficient methods for random sequence gen-
eration and only one study reported methods of allocation con-
cealment.
Attrition was high, which may be explained by study population,
types of assessment (e.g. completion and return of questionnaires)
or length of follow-up at 12 months or longer. Only one study
reported prospective clinical trials registration and was at low risk
of selective outcome reporting bias.
We noted differences in two studies in which participants in the
intervention group received resources in addition to follow-up
consultations, which may have influenced results, and we noted
differences in baseline characteristics (e.g. length of ICU stay)
within and between studies.
We included few randomised studies and evidence from one non-
randomised study, which we believed to have high risk of bias
because of its study design. We did not combine data from these
different types of study design. Overall, we had limited data for
each outcome, and meta-analysis included very few studies.
We considered study limitations identified from ’Risk of bias’ as-
sessments, differences between studies (in terms of time points of
measurement) and limited number of studies as reasons to down-
grade the certainty of evidence for each of our outcomes. We
judged evidence for HRQoL and PTSD to be low certainty, for
mortality to be moderate certainty, and for all other outcomes to
be very low certainty.
Potential biases in the review process
We conducted a thorough search, using two review authors to
assess eligibility, extract data, and assess risk of bias according to the
published protocol (Schofield-Robinson 2017). During the peer
review process, a referee identified one potentially relevant study
that our searches did not find (Jónasdóttir 2018). Consequently,
we have noted this study for future consideration and plan to re-
evaluate the search strategy for the next review update.
We did not contact authors of included studies during the review
process, and our reporting of data is limited to the information
in published reports. However, outcome data were sufficiently re-
ported in all studies, and we did not downgrade evidence during
GRADE assessments based on information that was missing (for
example, details of selection procedures), in the published report.
We edited the intervention criteria to include follow-up services
that were started within six months but may have continued be-
yond six months after ICU discharge. Four included studies had
follow-up services that occurred beyond six months and we be-
lieved that these were an appropriate design. Also, we extended the
time point at which end of follow-up data were collected beyond
12months because we found studies that continued follow-up ser-
vices up to 12 months after ICU discharge, and it was important
to include data assessed after these final follow-up consultations.
We believed that these edits did not introduce bias and increased
the generalisability of the evidence to a wide range of follow-up
services.
Agreements and disagreements with other
studies or reviews
Our review findings are broadly consistent with the findings of a
recent review by Jensen and colleagues, who concluded that, while
follow-up clinics might cause a minor decrease in post-traumatic
stress, there is no evidence of further effects (Jensen 2015). We
noted that Jensen and colleagues included studies of diary inter-
ventions, which were not included in this review, and which con-
tributed to the result for PTSD in Jensen 2015. Another review,
by Williams and colleagues in 2008, suggested that there was no
evidence of an effect of follow-up clinics, using similar outcomes
to the present review (Williams 2008).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Whilst we found little or no difference in outcomes between par-
ticipants who received a follow-up service and those who received
standard care, this review presented insufficient evidence to deter-
mine whether ICU follow-up services are effective. We included
only four randomised studies, and one non-randomised study,
with relatively few participants. In addition, this review concen-
trated on outcomes agreed during preparation of the protocol
(Schofield-Robinson 2017), and as such we have only attempted
to measure the effectiveness of an ICU follow-up service using
these outcomes. For example, we did not explore the number of
subsequent referrals to specialist services or participant satisfaction
with an ICU follow-up service versus standard care, and we did
not perform a cost-benefit analysis of ICU follow-up services.
As yet no consensus exists to quantify all the components of an
ICU follow-up service and subsequently evidence for this review
was from a wide-ranging definition of such a service. Because of
insufficient studies, we could not perform subgroup analysis; this
subgroup analysis sought to establish differences between models
of follow-up services. In addition, we could not determine that
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control groups in studies (in which participants received standard
care) were comparable; healthcare resources and existing services
after people leave the ICU may vary widely between hospital in-
stitutions and primary care services.
ICU follow-up continues to be a topical issue in global healthcare,
andwe are encouraged by the identificationof five ongoing studies.
Whilst effectiveness has not been demonstrated in this review,
neither have we concluded that ICU follow-up services are not
effective, and we anticipate that follow-up services will continue to
be developed in line with national policies (for example, following
the recommendation of multidisciplinary functional assessment
after ICU discharge; NICE 2009). Inclusion of ongoing studies
may influence the results of this review in future updates.
Implications for research
Further evidence is required to establish whether ICU follow-up
services are effective in addressing physical and psychological con-
sequences of an ICU stay. Because of insufficient studies, we were
unable to examine through subgroup analysis whether one design
of follow-up service was more effective than another, and it is
therefore not appropriate to propose one single design of follow-
up service to test in an interventional study. We expect that future
studies are likely at this stage to present different models of follow-
up service. However to reduce the risk of bias, we propose that the
follow-up service is the only variable between study groups (i.e.
the follow-up service does not include additional resources that
may confound data). We would encourage study authors to report
clear descriptions of standard care services. Randomised studies of
interventions are a more robust study design and would increase
certainty of an effect.
This review included studies only from high-income countries, in
which healthcare resources may be greater. We encourage addi-
tional research in low- andmiddle-income countries, which would
allow for an assessment of the effectiveness of an ICU follow-up
service in a wider variety of resource settings.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Cuthbertson 2009
Methods Randomised study
Multicentre (3 centres: 2 teaching hospitals and 1 district general hospital; in the UK:
high-income country)
Parallel design
Participant as the unit of allocation
Participants Total number of randomised patients: 286
Inclusion criteria: all patients receiving level 3 dependency (ICU) care at any time
during their hospital stay and who survived until hospital discharge
Exclusion criteria: patients < 18 years of age, not expected to survive to leave hospital,
unable to complete questionnaires or attend clinics, and who did not consent to partic-
ipate
Baseline characteristics
Follow-up service group
Age, median (IQR): 59 (46-49) years (as reported by study authors, we assumed that
there was a typo in these data)
Gender, male (%): 86 (60)
APACHE II, median IQR: 19 (15-24)
Reason for ICU admission: respiratory 48, cardiovascular 43, neurological 5, gastroin-
testinal 27, renal 5, metabolic/endocrine 2, haematological 0, trauma 13
HADS-A, median (IQR): 7 (3-10)
HADS-D, median (IQR): 6 (3-9)
SF-36 mental, mean (SD): 40.9 (± 15.2)
SF-36 physical, mean (SD): 33.4 (± 10.0)
EQ-5D, median (IQR): 0.52 (0.26-0.73)
Length of ICU stay, median (IQR): 2.9 (1.7-9.5) days
Control group
Age median (IQR): 60 (46-71) years
Gender male (%): 86 (60)
APACHE II median (IQR): 19 (15-24)
Reason for ICU admission: respiratory 42, cardiovascular 42, neurological 11, gastroin-
testinal 27, renal 3, metabolic/endocrine 2, haematological 1, trauma 15
HADS-A median (IQR): 7 (4-10)
HADS-D median (IQR): 5 (3-9)
SF-36 mental mean (SD): 41.4 (± 14.2)
SF-36 physical mean (SD): 32.6 (± 9.9)
EQ-5D, median (IQR): 0.49 (0.19-0.69)
Length of ICU stay, median (IQR): 3.1 (1.2-7.5) days
Interventions Follow-up service group
Randomised participants = 143, analysed participants at 6 months = 105; analysed
participants at 12 months = 92
Number of losses with reasons: 18 died; 6 formally withdrew; 16 lost to follow-up. 6
did not complete questionnaire at 6 months but completed it at 12 months. Then at 12
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months, 18 died, 11 formal withdrawal; 22 lost-to follow-up
Description of service: participants were given a manual-based, self-directed, physical re-
habilitation programme developed by a physiotherapist and introduced by a study nurse.
Participants were formally reviewed at a face-to-face clinic, which included structured
case review, discussion of experiences of the ICU, formal assessment of requirement for
specialist medical referral, screening for psychological morbidity relating to admission
to the ICU
Number and timing of follow-up clinics: 2 clinics (1 at 3 months and 1 at 9 months
after ICU discharge)
Co-ordinator of service: nurse-led
Number of participants in clinic attendance: 104 at 3 months; 94 at 9 months
Number of carers or family members in clinic attendance at 3 months: 46; and at 9
months: 31
Subsequent referrals to other services: referrals made if required
Control group
Randomised participants = 143, analysed participants at 6 months = 115; analysed
participants at 12 months = 100
Number of losses with reasons: 7 died; 15 lost to follow-up; 6 did not complete ques-
tionnaire at 6 months but completed it at 12 months. Then at 12 months, 14 died; 2
formal withdrawal; 27 lost to follow-up
Description of service: follow-up in accordance with standard clinical practice with no
ICU follow-up after hospital discharge. Participants followed up by GP and primary
hospital specialty
Outcomes 1. HRQoL (EQ-5D: lower scores indicate better HRQoL; at 6 and 12 months)
2. Cognitive function (SF-36 MCS: higher scores indicate less impairment; at 6 and
12 months)
3. Mortality (12 months)
4. Depression (using HADS-D: lower scores indicate less depression; at 6 and 12
months)
5. Anxiety (using HADS-A: lower scores indicate less anxiety; at 6 and 12 months)
6. PTSD (using DTS; lower scores indicate less distressing symptoms of PTSD; at 6
and 12 months)
7. Ability to return to work
8. Cost effectiveness (primary and secondary healthcare costs in the year after
hospital discharge, QALYs, at 12 months).
All outcomes measured by postal questionnaire
Notes Funding/declarations of interest: “the study is supported by a research grant from
the Chief Scientist Office of the Scottish Government Health Directorates. The Health
Services Research Unit is also funded by the Chief Scientist Office of the Scottish Gov-
ernment Health Directorates. The researchers are completely independent of the fun-
ders, and the views expressed are those of the authors alone. The study sponsor was the
University of Aberdeen, which had no role in the study design; collection, analysis, and
interpretation of data; writing of the article; or the decision to submit it for publication.
The researchers are completely independent of the sponsors in their research activities.”
Study dates: September 2006-October 2007
Note: study authors reported effect estimates that were adjusted for minimisation co-
variates (age, sex, HADS score, APACHE II score, ICE score and study centre
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Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computerised telephone randomisation
service
Allocation concealment (selection bias) Unclear risk No evidence of attempts to conceal alloca-
tion
Blinding of participant and personnel (per-
formance bias)
Unclear risk Not feasible to blind personnel and partic-
ipants to study. It is unclear whether this
may have influenced performance
Blinding of outcome assessors (detection
bias)
Unclear risk Self-reported outcome collection through
completion of questionnaires. It is possi-
ble that this may have influenced outcome
data because participants were aware of in-
tervention. Researchers handling outcome
data from questionnaires were blinded
Incomplete outcome data (attrition bias) Unclear risk High loss of participants, but this loss may
be explained by illness severity of partici-
pants. Also, we noted some discrepancies
with denominator data in outcome tables,
and the number of analysed participants
differed for each outcome
Selective reporting (reporting bias) Unclear risk Retrospective registration with clinical tri-
als register: ISRCT24294750. Not feasible
to judge risk of selective outcome reporting
Protection against contamination Low risk StandardNHS pathway, rigorously applied
to ensure standardisation
Baseline characteristics Unclear risk Randomisation service incorporated base-
line minimisation. We could not be cer-
tain whether ages were balanced between
groups because we noted median age of
participants in the intervention group in-
cluded an error
Other bias High risk Participants in the intervention group also
received a manual-based physiotherapy
programme, which required participants
to monitor their own compliance. Partic-
ipants in the control group did not re-
ceive this. It is possible that this programme
could have influenced results, rather than
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the clinic appointment
Douglas 2007
Methods Randomised study
Single-centre (950-bed tertiary care facility; University Hospitals of Cleveland, USA; a
high-income country)
Parallel design
Participant as the unit of allocation
Participants Total number of randomised patients: 334
Inclusion criteria: patients who required mechanical ventilation for > 72 h, at high
risk for death or prolonged hospitalisation with multi-organ dysfunction and continuing
care needs after discharge from the hospital. No ventilator dependency before the index
hospitalisations, and discharge location within 80 miles of the study site
Exclusion criteria: hospice patients and patients who had received organ transplants
and case management from the transplant team
Baseline characteristics
Follow-up service group
Age, mean (SD): 60.7 (± 16.6) years
Gender, male (%): 100 (43.3)
Ethnicity, n (%): 146 white (63.5)
APACHE III, mean (SD): 56.6 (± 26.3)
Reason for ICU admission: pulmonary disease 51, coronary artery disease 54, neurolog-
ical abnormalities 46, other 80
SF-8 mental, mean (SD): 41.9 (± 12.8)
SF-8 physical, mean (SD): 30.6 (± 8.7)
Length of ICU stay, mean (SD): 17.3 (± 12.9) days
Control group
Age, mean (SD): 61.4 (± 16.1) years
Gender, male (%): 47 (45.6)
Ethnicity, n (%): 60 white (58.3)
APACHE III, mean (SD): 63.8 (± 24.3)
Reason for ICU admission: pulmonary disease 31, coronary artery disease 19, neurolog-
ical abnormalities 13, other 40
SF-8 mental, mean (SD): 42.9 (± 13.3)
SF-8 physical mean (SD): 35.8 (± 10.5)
Length of ICU stay, mean (SD): 16.9 (± 14.9) days
Pretreatment: note differences in APACHE III scores between groups. Also, HRQoL
mean physical score at discharge is higher for the control group
Interventions Follow-up service group
Randomised participants = 231, analysed participants = 180
Number of losses with reasons: died 43, dropped out 6, lost to follow-up 2
Description of service: most participants received face-to-face follow-up. Some partici-
pants received telephone follow-up (52/231, 22.5%). Service was verbal
Number and timing of follow-up clinics: meeting with participant and family before
hospital discharge. Nurse completed a discharge summary plan, which was sent to all
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relevant out-of-hospital healthcare providers. Then participants received a visit within
48 h, and another visit within the first week, then at least weekly for next 3 weeks,
and at least every other week for 4 weeks with minimum of 8 visits. Visits took place
at participant’s home or extended care facility and included case management activities
relevant to the participant’s condition and needs. Participants/carers had access to pager
24 h/day
Co-ordinator of service: nurse-led (advance practice nurse)
Number of participants who received follow-up service: 180
Carers or family members were included in follow-up service
Subsequent referrals to other services were made
Control group
Randomised participants = 103, analysed participants = 67
Number of losses with reasons: died 20, dropped out 9, lost to follow-up 7
Description of service: no contact with advanced practice nurse. Interviewed by study
nurses within 2weeks of discharge for completion of study instruments, then at 2months
after discharge for data collection. If advice was needed, participants were referred to
their primary care provider, staff at extended care facility or home care agency
Outcomes 1. Physical function (assessed as HRQoL outcome using SF-8: higher scores indicate
less physical disability; at 2 months);
2. Mortality (at 2 months)
Notes Funding/declarations of interest: this studywas funded by grant RO1-NR0-0527 from
the National Institute of Nursing Research
Study dates: March 2001-December 2003
Note:
1. Measures of baseline HRQoL were reported by participants or carers at discharge
with reference to health status in the week before ICU admission.
2. Randomisation completed with ratio of 2:1 (intervention group: control group),
which was changed to 4:1 in final 14 months of the study (study authors do not
explain reasons for this ratio).
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Block randomisation in ratio of 2:1, which
was later changed to 4:1. No additional de-
tails
Allocation concealment (selection bias) Unclear risk No evidence of attempts to conceal alloca-
tion
Blinding of participant and personnel (per-
formance bias)
Unclear risk Not feasible to blind participants or nurses
to intervention. It is unclear whether this
may have influenced performance
35Follow-up services for improving long-term outcomes in intensive care unit (ICU) survivors (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Douglas 2007 (Continued)
Blinding of outcome assessors (detection
bias)
Unclear risk Self-reported assessment at baseline. Study
authors do not describe who assessed out-
comes at 2 months, but we assumed out-
comes were self-reported
Incomplete outcome data (attrition bias) Unclear risk High number of participant loss, withmore
losses in the control group
Selective reporting (reporting bias) Unclear risk Study authors do not report clinical trials
registration. Not feasible to assess risk of
selective outcome reporting
Protection against contamination Low risk Follow-up service was operated by trained
nurses, and it is unlikely that the control
group received the intervention
Baseline characteristics High risk Study authors acknowledge that baseline
characteristics (APACHE III and HRQoL
physical function) are unequal
Other bias High risk Intervention began before participants
were discharged from hospital. Partici-
pants/families in the intervention group
were involved in discharge summary plan,
which was circulated to all out-of-hospital
teams. This may have influenced outcome
data relative to other studies in which fol-
low-up started after discharge
Jensen 2016
Methods Randomised study
Multicentre (10 ICUs; in Denmark; a high-income country)
Parallel design
Participant as the unit of allocation
Participants Total number of randomised patients: 386
Inclusion criteria: Danish-speaking adults (≥ 18 years of age) who had been mechani-
cally ventilated ≥ 48 h and who did not meet criteria for baseline dementia
Exclusion criteria: participants, who were not oriented in personal data according to
the verbal response in GCS, with detected delirium using CAM-ICU at randomisation,
or enrolled in other follow-up studies
Baseline characteristics
Follow-up service group
Age, median (IQR): 66 (57.75-73.5) years
Gender, male (%): 112 (58.9)
APACHE II, median (IQR): 25 (19.0-30.3), SAPS II median (IQR): 44.5 (35.0-54.3)
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Duration of sedation, median (IQR): 159.1 (83.5-384.7) h
Reason for ICU admission: neurological 12, respiratory 70, cardiovascular 26, gastroin-
testinal 21, renal 1, haematological 1, metabolic/endocrine 0, sepsis 56, trauma/intoxi-
cations 3
Days of delirium, median (IQR): 0 (1-2)
Length of ICU stay, median (IQR): 10 (5-20) days
Control group
Age, median (IQR): 67.5 (58-75) years
Gender, male (%): 117 (59.7%)
APACHE II, median (IQR): 24.5 (20.0-30.0), SAPS II, median (IQR): 48.5 (39.3-60.
0)
Reason for ICU admission: neurological 12, respiratory 70, cardiovascular 26, gastroin-
testinal 21, renal 1, haematological 1, metabolic/endocrine 0, sepsis 56, trauma/intoxi-
cations 3
Days of delirium, median (IQR): 0 (0-1)
Length of ICU stay, median (IQR): 9 (16-18) days
Interventions Follow-up service group
Randomised participant = 190, analysed participants = 116
Number of losses with reasons: did not fulfil inclusion criteria 2, did not receive inter-
vention 54, invalid questionnaire 20, died 53, did not respond for other reasons 64
Description of service: participants received an information pamphlet ’Life after ICU’.
First, consultation at clinic with participant and close relative at 1-3 months post-ICU.
Intention was to construct an illness narrative; dialogue was aided by using photographs
of the participant taken by ICU nurses during participant recovery. Second and third
consultations were at 5 and 10 months post-ICU, by telephone; prior to these telephone
calls participants completed a reflective sheet by finishing pre-set sentences (e.g. “What
I want most is...”)
Number and timing of follow-up clinics: 3 clinics (1 face-to face clinic at 3 months.
Telephone calls at 5 and 10 months)
Co-ordinator of service: nurse-led
Number of participants in clinic attendance: 1st session: 136/190; 2nd session: 120/
190, 3rd session: 110/190
Carers or family members were invited to attend clinic
Subsequent referrals to other services were made
Control group
Randomised participants = 196, analysed participants = 119
Number of losses with reasons: did not fulfil inclusion criteria 5, did not receive inter-
vention 3, invalid questionnaire 18, died 85, did not respond for other reasons 64
Description of service: ICU discharge without follow-up
Outcomes 1. HRQoL (using SF-36 MCS and PCS: higher scores indicate less mental or
physical disability; at 12 months. Also using SOC at 3 months)
2. Mortality (at 12 months)
3. Depression and anxiety (using HADS-D and HADS-A: lower scores indicate less
anxiety and depression; at 3 and 12 months)
4. PTSD (using Harvard Trauma Questionnaire Part IV: study authors used cut-off
score ≥ 40 to indicate PTSD; at 3 and 12 months)
5. Utilisation of healthcare services
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Notes Funding/declarations of interest: the study was supported by grants from the Danish
Nursing Organization, The Novo Nordisk Foundation and Nordsjællands Hospital,
University of Copenhagen, Denmark. None of these had any influence on the design or
conduct of the study; data collection, data management, analysis, and interpretation of
the data; or findings
Study dates: December 2012-December 2015
Note: study authors reported effect estimates that adjusted for study centres
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Random sequence generation, but no ad-
ditional details
Allocation concealment (selection bias) Low risk Allocation was concealed in sealed, opaque
envelopes
Blinding of participant and personnel (per-
formance bias)
Unclear risk Not feasible to blind participants or per-
sonnel. It is unclear whether this may have
influenced performance
Blinding of outcome assessors (detection
bias)
Unclear risk Unclear as to whether outcome assessors
were blind, and some outcomes were self-
reported
Incomplete outcome data (attrition bias) Unclear risk Large loss of participant data
Selective reporting (reporting bias) Low risk Prospective
clinical trials registration NCT01721239.
Outcomes are reported according to pre-
published documents
Protection against contamination Low risk Limited risk of contamination based on de-
tails of intervention and professional deliv-
ery
Baseline characteristics Low risk Well-balanced groups
Other bias Low risk No additional sources of bias identified
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Schandl 2012
Methods Non-randomised study (using a before-after design)
Single-centre (general ICU; in Sweden; a high-income country)
Parallel design
Participant as the unit of allocation
Participants Total number of randomised patients: 410
Inclusion criteria: patients ≥ 16 years of age, treated for > 96 h in the general ICU
Exclusion criteria: patients that did not speak Swedish and patients with no address
Baseline characteristics (for those who received the questionnaire)
Follow-up service group
Age, mean (SD): men 53 (± 17) years; women 52 (± 18) years
Gender, male (%): 102 (65)
APACHE II, mean (SD): men 23 (± 9); women 21 (± 8)
Reason for ICU admission: participants categorised in terms of trauma, surgical, medical,
infection
Length of ICU stay, mean (SD): men: 11 (± 7) days; women: 10 (± 7) days
Duration of sedation, median (IQR): men 3 (1-6) h; women 3 (1-5) h
Control group
Age, mean (SD): men: 52 (± 17) years; women: 54 (± 20.5) years
Gender, male (%): 64 (63)
APACHE II, mean (SD): men 21 (± 8); women 19 (± 10)
Reason for ICU admission: participants categorised in terms of trauma, surgical, medical,
infection
Length of ICU stay, mean (SD): men 9 (± 7) days; women 9 (± 8) days
Duration of sedation, median (IQR): men 2 (0-4) h; women 2 (0-4) h
Interventions Follow-up service group
Randomised participants = 259, analysed participants = 102men and 54women received
questionnaire at 14 months, of which 98 participants responded
Number of losses with reasons: 103 excluded or lost to follow-up, only 98 responded to
the questionnaire
Description of service: face-to-face. Multidisciplinary follow-up consultations in which
participants met a nurse, physician, and physiotherapist from the general ICU. Location
of consultation is not reported in the study report, but we assumed that these were in a
hospital clinic setting
Number and timing of follow-up clinics: within 1 week from ICU discharge, nurse
visited participant on the ward. Then offered multidisciplinary follow-up consultations
at 3, 6, and 12 months after ICU
Co-ordinator of service: nurse and physician-led
Materials involved: the consultation involved re-stating ICU care and treatment. Memo-
ries, delusions and/or nightmares identified with the ICU-Memory-Tool were discussed,
functional status also assessed
Subsequent referrals to other services were made.
Control group
Number randomised: 151. Number analysed: receiving questionnaire at 14 months: 64
men, 38 women. 73 participants responded
Number of losses with reasons: 49 lost to follow-up and then only 73 responded to
questionnaire
Description of service: no ICU follow-up was available. Participants were called for
routine surgical or medical follow-up consultations
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Outcomes 1. Mortality
2. Depression and anxiety (using HADS-D and HADS-A: lower scores indicate less
anxiety and depression; at 14 months). Assessed at each consultation
3. PTSD (using IES: lower scores indicate less distressing symptoms of PTSD; at 14
months)
Notes Funding/declarations of interest: grants from Lena and Per Sjöberg Research Foun-
dation and the Karolinska University Hospital and Karolinska Institutet Committé of
Strategic Research
Study dates: January-December 2006 for the control group, January 2007-September
2008 for the intervention group
Note: study aim was to compare psychological morbidity and treatment effects between
men and women and all study results are reported by gender. Study authors reported
median scores, with percentiles, which were unadjusted and adjusted (for age, length
of ICU stay, and previous psychological problems); we reported adjusted percentile
differences
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Non-randomised study with a before-after
study design
Allocation concealment (selection bias) High risk No randomisation process, therefore no
group allocation concealment
Blinding of participant and personnel (per-
formance bias)
Unclear risk Not feasible to blind participants or per-
sonnel. It is unclear whether this may have
influenced performance
Blinding of outcome assessors (detection
bias)
Unclear risk No evidence of blinding of outcome asses-
sors. Self-reported outcomes
Incomplete outcome data (attrition bias) Unclear risk High participant losses, adequately ex-
plained
Selective reporting (reporting bias) Unclear risk Study authors do not report clinical trials
registration. Not feasible to assess risk of
reporting bias
Protection against contamination High risk Risk of contamination high because of time
period difference in control and interven-
tion groups, during which other variables
in service delivery may have changed
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Baseline characteristics High risk More women had a previous psychological
problem in the control group. We noted
that ICU length of stay was longer in in-
tervention group, and we noted some dif-
ferences in types of diagnoses, and median
duration of sedation
Also, we noted that baseline characteristics
were only reported for those who received a
questionnaire at 14 months post-ICU dis-
charge
Other bias Low risk We identified no other sources of bias
Schmidt 2016
Methods Randomised study
Multicentre (9 ICUs; in Germany; a high-income country)
Parallel design
Participant as the unit of allocation
Participants Total number of randomised patients: 291
Inclusion criteria: adult (≥ 18 years of age) survivors of severe sepsis or septic shock,
and were fluent in German
Exclusion criteria: cognitive impairment as determined by a telephone interview of
cognitive status
Baseline characteristics
Follow-up service group
Age, mean (SD): 62.1 (± 14.1) years
Gender, male (%): 105 (70.9)
Reason for ICU admission: sepsis
SF-36 mental, mean (SD): 48.8 (± 12.5)
SF-36 physical mean (SD): 25.9 (± 9.4)
Length of ICU stay, mean (SD): 31.5 (± 27.7) days
Control group
Age, mean (SD): 61.2 (± 14.9) years
Gender, male (%): 87 (61.3)
Reason for ICU admission: sepsis
SF-36 mental mean (SD): 49.2 (± 12.6)
SF-36 physical mean (SD): 24.7 (± 8.0)
Length of ICU stay, mean (SD): 35.2 (± 26.7) days
Interventions Follow-up service group
Randomised participants = 148, analysed participants at 6 months = 104
Number of losses with reasons: 32 withdrew from study, 4 missed the 6-month follow-
up, 8 were excluded for missing data
Description of service: structured, nurse-led intervention post-discharge aimed at iden-
tifying and dealing with likely sequelae of critical illness. Nurses were trained to identify
sepsis sequelae, and monitored participants’ symptoms using validated screening tools;
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problems were escalated with referrals if necessary. This was a primary care-based inter-
vention, involving training of participants and primary care providers, telephone moni-
toring
Number and timing of follow-up clinics: initial training on sepsis sequelae 8 days post-
ICU discharge, then monthly telephone follow-up for 6 months, then every 3 months
for the subsequent 6 months
Co-ordinator of service: nurses
Carer or family member were not invited to attend clinic because this was a telephone-
based service
Subsequent referrals to other services were made
Control group
Randomised participants = 143, analysed participants at 6 months = 96
Number of losses with reasons: 34 withdrew from study, 1 missed the 6-month follow-
up, 11 were excluded for missing data
Description of service: usual care by primary care provider
Outcomes 1. Change in HRQoL mental component (using SF-36: higher scores indicate less
impairment; at 6 months and 12 months)
2. Change in HRQoL physical component (using SF-36: higher scores indicate less
impairment; at 6 and 12 months)
3. Mortality (at 12 months)
4. PTSD (using PTSS-10: lower scores indicate less distressing symptoms of PTSD;
at 6 and 12 months)
5. ADL impairments and sleep impairments (at 6 and 12 months)
6. Chronic pain (at 6 and 12 months)
7. Malnutrition (at 6 and 12 months)
Notes Funding/declarations of interest: the study was supported by the CSCC, funded by
the German Federal Ministry of Education and Research and the German Sepsis Society
Study dates: February 2011-December 2013
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated random permutated
blocks were used
Allocation concealment (selection bias) Unclear risk No evidence of attempts to conceal alloca-
tion
Blinding of participant and personnel (per-
formance bias)
Unclear risk Not feasible to blind participants or per-
sonnel. It is unclear whether this may have
influenced performance
Blinding of outcome assessors (detection
bias)
Unclear risk Some outcomes were self-reported. Not
clear whether outcome assessors were
blinded
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Incomplete outcome data (attrition bias) Unclear risk Moderate levels of patient attrition, but ex-
plained adequately
Selective reporting (reporting bias) Unclear risk Retrospective clinical trials registration;
therefore, unclear whether bias has been in-
troduced
Protection against contamination Low risk Limited risk of contamination based on de-
tails of intervention and professional deliv-
ery
Baseline characteristics Low risk No evidence of major baseline characteris-
tics differences
Other bias Low risk No evidence of additional bias
ADL: activities in daily living; APACHE II (or APACHE III): Acute Physiology and Chronic Health Evaluation II (or III); CAM-
ICU: Confusion Assessment Method for the intensive care unit; CSCC: Center for Sepsis Control and Care; DTS: Davidson
Trauma Scale; EQ-5D: Euroqol 5D; GCS: Glasgow Coma Score; GP: general practitioner; h: hour(s); HADS: Hospital Anxiety
and Depression score; HADS-A: Hospital Anxiety and Depression score for anxiety; HADS-D: Hospital Anxiety and Depression
score for depression; HRQoL: health-related quality of life; HTQ-IV: Harvard Trauma Questionnaire Part IV; ICE: intensive care
experience; IES: Impact of Event Scale; ICU: intensive care unit; IQR: interquartile range; MCS: mental component score; n:
number of participants; PCS: physical component score; PTSD: post-traumatic stress disorder; PTSS-10: Post Traumatic Symptom
Scale; QALYs: quality of life years; SAPS: Simplified Acute Physiology Score; SD: standard deviation; SF-36: Short Form-36; SF-
8: Short Form-8; SOC: Sense of Coherence
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Alberto 2011 Wrong intervention: liaison nurse providing education rather than a follow-up service used to assess
unmet health needs related to the ICU period
Backman 2010 Wrong intervention: ICU diary study rather than a follow-up service used to assess unmet health needs
related to the ICU period
Ball 2003 Wrong patient population: ward-based patients, not ICU patients
Bourseau 2016 Adult ICU patients (> 18 years of age), mechanically ventilated for ≥ 5 days. Participants were examined
1 month after ICU discharge by a multidisciplinary team. Study published as an abstract only, which
contains insufficient information to justify inclusion. We attempted to contact the study authors by email
(on 1 occasion), which was unsuccessful. We will reassess eligibility if this study is published in full, and
if it is eligible, we will incorporate the study results in a future review update
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Cave 2016 Adult patients, discharged from the ICU. Intervention includes an ICU follow-up day clinic programme.
Study published as an abstract only, which contains insufficient information to justify inclusion. We
attempted to contact the study authors by email (on 1 occasion), which was unsuccessful. We will re-
assess eligibility if this study is published in full, and if it is eligible, we will incorporate the study results
in a future review update
Cox 2014 Wrong intervention: specific psychotherapy intervention rather than a follow-up service used to assess
unmet health needs related to the ICU period
Cox 2017 Wrong intervention: training programme rather than a follow-up service used to assess unmet health
needs related to the ICU period
Davidson 2015 Adult ICU survivors with ARDS or septic shock, mechanically ventilated for > 24 h. Participants attended
a structured clinic with a medication review consultation and an assessment of physical function and
evaluation of ongoing issues related to their illness. Study published as an abstract only, which contains
insufficient information to justify inclusion. We attempted to contact the study authors by email (on 1
occasion), which was unsuccessful. We will re-assess eligibility if this study is published in full, and if it
is eligible, we will incorporate the study results in a future review update
Farazmand 2017 Wrong patient population; CCU patients, and were exposed to level 2 care, instead of the level 3 care our
review required
Garrouste-Orgeas 2010 Wrong intervention: diary study rather than a follow-up service used to assess unmet health needs related
to the ICU period
Holmes 2007 Wrong intervention: specific form of psychotherapy rather than a follow-up service used to assess unmet
health needs related to the ICU period
Huynh 2017 Wrong intervention: diary study rather than a follow-up service used to assess unmet health needs related
to the ICU period
IRCT201110197844N1 Wrong intervention: educational package rather than a follow-up service used to assess unmet health
needs related to the ICU period
ISRCTN97280643 Wrong intervention: cognitive behavioural therapy rather than a follow-up service used to assess unmet
health needs related to the ICU period
Jackson 2012 Wrong intervention: cognitive rehabilitation rather than a follow-up service used to assess unmet health
needs related to the ICU period
Jones 2003 Wrong intervention: both groups received follow-up service. Intervention group received self-helpmanual
rather than a follow-up service used to assess unmet health needs related to the ICU period
Jones 2010 Wrong intervention: ICU diary study rather than a follow-up service used to assess unmet health needs
related to the ICU period
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Knowles 2009 Wrong intervention: ICU diary study rather than a follow-up service used to assess unmet health needs
related to the ICU period
NCT00976807 Wrong intervention: education and physical rehabilitation programme rather than a follow-up service
used to assess unmet health needs related to the ICU period
NCT02067559 Wrong intervention: ICU diary and psychoeducation programme rather than a follow-up service used to
assess unmet health needs related to the ICU period
NCT02415634 Wrong intervention: education and rehabilitation programme rather than a follow-up service used to
assess unmet health needs related to the ICU period
Ramnarain 2015 Patients who were treated in an ICU for > 5 days. Participants attended a post-ICU aftercare clinic. Study
published as an abstract only, which contains insufficient information to justify inclusion. We attempted
to contact the study authors by email (on 1 occasion), which was unsuccessful. We will re-assess eligibility
if this study is published in full, and if it is eligible, we will incorporate the study results in a future review
update
Robson 2008 Wrong intervention: ICU diary study rather than a follow-up service used to assess unmet health needs
related to the ICU period
Shaw 2012 Wrong intervention: education and psychological support programme rather than a follow-up service
used to assess unmet health needs related to the ICU period
Strahan 2003 Wrong intervention: education programme rather than a follow-up service used to assess unmet health
needs related to the ICU period
Walsh 2015 Wrong intervention: rehabilitation programme rather than a follow-up service used to assess unmet health
needs related to the ICU period
ARDS: acute respiratory distress syndrome; CCU: coronary care unit;ICU: intensive care unit
Characteristics of ongoing studies [ordered by study ID]
ACTRN12616000206426
Trial name or title Survivors of intensive care with type two diabetes and the effect of shared care follow-up clinics: the SWEET-
AS feasibility study
Methods Randomised study, parallel design
Participants Target number of participants: 80
Inclusion criteria: 18-85 years of age, established pre-admission diagnosis of type 2 diabetes mellitus, dis-
charged from ICU after ≥ 5 days of ICU care
Exclusion criteria: distance from hospital to home < 50 kilometres, > 85 years of age, major psychiatric
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ACTRN12616000206426 (Continued)
illness, anticipated to die within six months of ICU discharge, pregnancy
Interventions All patients in the intervention group will receive a 10-min telephone call from a research co-ordinator or
1 of the investigators 2 weeks after hospital discharge as a reminder of the upcoming clinic appointment.
During this telephone call, inquiries about significant hypoglycaemic (blood glucose level < 4 mmol/L) or
hyperglycaemic (blood glucose level > 13 mmol/L) blood concentrations will be made. If necessary, changes
in treatment will be instituted by the study diabetologist and recorded for each participant. Attendance at
a shared care follow-up clinic will occur 1 month after hospital discharge (+/- 14 days). Participants will be
assessed by both an intensivist and a diabetologist at the clinic (2 separate 45-min appointments with each
staff member at a single clinic visit)
Outcomes Study feasibility, anthropometric measurements, glycaemic control, distal peripheral neuropathy, cardiovascu-
lar autonomic neuropathy, nephropathy, HRQoL (using EQ-5D and SF-36), employment status, healthcare
utilisation
Starting date 14 February 2016
Contact information Dr Yasmine Ali Abdelhamid (yasmine.aliabdelhamid@sa.gov.au)
Notes Feasibility study
NCT01796509
Trial name or title Multicenter randomised, controlled trial of a intensive care follow-up programme in improving long-term
outcomes of ICU survivors
Methods Randomised study, parallel design
Participants Target number of participants: 600
Inclusion criteria: > 18 years of age, living in an area near the hospital, hospitalised in the ICU medical
surgical hospitals in this study, required mechanical ventilation > 3 days, life expectancy > 1 year, having a
GP identified, affiliated to a social health care, informed consent
Exclusion criteria: patients hospitalised in ICU in the previous year, patients followed for a pre-existing
myopathy, burn patients, patients with brain injury (GCS < 8) or trauma, patients hospitalised for suicide or
self-induced poisoning, patients with psychiatric disorders, patients with dementia, pregnant women, patients
who do not speak fluent French, patients with guardianship, homeless patients, having no GP identified
Interventions In the intervention group, medical, psychological and social consultation will be planned within the first 7
days after inclusion, and then at 3, 6, and 12 months. During medical consultation a general examination
will be performed, and muscle strength, cognitive function, and functional disabilities will be assessed
Outcomes Quality of life, anxiety and depression, social re-insertion, economic healthcare costs
Starting date December 2012
Contact information -
Notes
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NCT02077244
Trial name or title A randomised controlled trial to evaluate the effect of nurse led follow up after being a patient in the intensive
care unit
Methods Randomised study, parallel design
Participants Target number of participants: 250
Inclusion criteria: adult patients with an ICU stay ≥ 24 h who speak and understand Norwegian and who
are conscious and cognitively oriented at the time of inclusion
Exclusion criteria: severe psychiatric disorder
Interventions Nurse-led follow-up talks on the ward, and at 1 and 2 months later
Outcomes Change from baselines measures for: PTSD, pain, HRQoL, sense of coherence, work participation
Starting date March 2014
Contact information Kirsti Tøien (kirsti.toien@ous-hf.no)
Notes
NCT03124342
Trial name or title Vanderbilt ICU recovery program pilot trial
Methods Randomised study, parallel design
Participants Target number of participants: 550
Inclusion criteria: patients > 18 years of age, admitted to theMICU at Vanderbilt University Medical Center
for ≥ 48 h, who had an estimated risk of 30-day same-hospital readmission > 15%, and who were not
previously enrolled on the study
Exclusion criteria: long-term residence at a skilled nursing facility, long-term mechanical ventilation prior to
admission, solid organ or stem cell transplantation, recorded primary residency > 200 miles from Vanderbilt,
comfort care only
Interventions 10-component ICU recovery programme intervention, including: nurse practitioner in-person visit at the
time of transfer from the ICU; provision of an ICU recovery programme pamphlet describing post-intensive
care syndrome and providing online resources; performance of formal medication reconciliation at the time
of transfer from the ICU, access to a dedicated 24-h/day, 7-day/week contact line; ICU recovery clinic visit
medical examination, ICU recovery clinic medication reconciliation and counselling; ICU recovery clinic
cognitive/mental health assessment and psychoeducation. A brief session of psychotherapy conducted by a
clinical psychologist; ICU recovery clinic case management. A brief case management consultation; ICU
recovery clinic patient-centred consultation. A final consultation with patients and families by a physician;
directed subspecialty referrals
Outcomes Number of components of the ICU recovery programme received, same-hospital readmission in the 30 days
after hospital discharge, readmission-free days, death or readmission in the 30 days after hospital discharge,
number of same-hospital emergency department visits in the 30 days after hospital discharge, number of
same-hospital outpatient clinic visits in the 30 days after hospital discharge, number of referrals to specialty
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NCT03124342 (Continued)
providers
Starting date 1 May 2017
Contact information Matthew W Semler (matthew.w.semler@vanderbilt.edu)
Notes
Paratz 2014
Trial name or title IMPOSE (improving outcomes after sepsis) - the effect of a multidisciplinary follow-up service on health-
related quality of life in patients postsepsis syndromes - a double-blinded randomised controlled trial: protocol
Methods Randomised study, parallel design
Participants Target number of participants: 204
Inclusion criteria: participants will be recruited from among patients being discharged from a quaternary
university-affiliated ICU at Royal Brisbane and Women’s Hospital, Brisbane, Australia. Patients > 18 years of
age, with a documented episode of sepsis, plus proven or strongly suspected infection, severe sepsis defined as
sepsis plus organ failure, septic shock (defined as severe sepsis not responding to management) and requiring
respiratory support for > 48 h
Exclusion criteria: neurological injuries, spinal injuries and burns. Patients with haematological conditions
or requiring palliative care post-ICU. Patients with psychiatric and/or mental disabilities that preclude them
from understanding the questionnaires, and non-English speaking patients
Interventions Participants in the intervention group will attend a follow-up clinic twice a month for up to 6 months
after discharge from the hospital. Screening instruments will be utilised on the first visit and appropriate
management and referral provided. Following the results of the screening and team discussion, participants
and/or carer will be referred to appropriate agencies
Outcomes HRQoL (using SF-36), participants’ readmission rates to hospital (medical record data), mortality at 12
months and economics and healthcare resource use
Starting date 3 June 2013
Contact information Dr Jennifer Paratz (j.paratz@uq.edu.au)
Notes
EQ-5D: Euroqol-5D;GCS:Glasgow Coma Score;GP: general practitioner;HRQoL: health-related quality of life;ICU: intensive care
unit; MICU: medical intensive care unit; PTSD: post-traumatic stress disorder; SF-36: short form-36
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D A T A A N D A N A L Y S E S
Comparison 1. Follow-up service vs control
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 All-cause mortality 4 1289 Risk Ratio (M-H, Random, 95% CI) 0.96 [0.76, 1.22]
2 Physical function 2 422 Mean Difference (IV, Fixed, 95% CI) 1.31 [-0.86, 3.49]
3 Cognitive function 3 622 Mean Difference (IV, Fixed, 95% CI) 1.44 [-0.51, 3.39]
4 PTSD 3 703 Std. Mean Difference (Fixed, 95% CI) -0.05 [-0.19, 0.10]
Analysis 1.1. Comparison 1 Follow-up service vs control, Outcome 1 All-cause mortality.
Review: Follow-up services for improving long-term outcomes in intensive care unit (ICU) survivors
Comparison: 1 Follow-up service vs control
Outcome: 1 All-cause mortality
Study or subgroup Follow-up service Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Cuthbertson 2009 (1) 18/138 14/140 13.3 % 1.30 [ 0.68, 2.52 ]
Douglas 2007 (2) 43/231 20/103 25.2 % 0.96 [ 0.60, 1.54 ]
Jensen 2016 (3) 36/190 43/196 36.7 % 0.86 [ 0.58, 1.28 ]
Schmidt 2016 (4) 27/148 27/143 24.8 % 0.97 [ 0.60, 1.56 ]
Total (95% CI) 707 582 100.0 % 0.96 [ 0.76, 1.22 ]
Total events: 124 (Follow-up service), 104 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.11, df = 3 (P = 0.77); I2 =0.0%
Test for overall effect: Z = 0.31 (P = 0.76)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours follow-up service Favours control
(1) Measured at 12 months
(2) Measured at 2 months
(3) Measured at 12 months
(4) Measured at 12 months
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Analysis 1.2. Comparison 1 Follow-up service vs control, Outcome 2 Physical function.
Review: Follow-up services for improving long-term outcomes in intensive care unit (ICU) survivors
Comparison: 1 Follow-up service vs control
Outcome: 2 Physical function
Study or subgroup Follow-up service Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Cuthbertson 2009 90 42 (10.6) 97 40.8 (11.9) 45.4 % 1.20 [ -2.03, 4.43 ]
Jensen 2016 116 39.06 (11.4966) 119 37.65 (11.4966) 54.6 % 1.41 [ -1.53, 4.35 ]
Total (95% CI) 206 216 100.0 % 1.31 [ -0.86, 3.49 ]
Heterogeneity: Chi2 = 0.01, df = 1 (P = 0.92); I2 =0.0%
Test for overall effect: Z = 1.19 (P = 0.24)
Test for subgroup differences: Not applicable
-10 -5 0 5 10
Favours Follow-up service Favours Control
Analysis 1.3. Comparison 1 Follow-up service vs control, Outcome 3 Cognitive function.
Review: Follow-up services for improving long-term outcomes in intensive care unit (ICU) survivors
Comparison: 1 Follow-up service vs control
Outcome: 3 Cognitive function
Study or subgroup Follow-up service Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Cuthbertson 2009 (1) 90 47.1 (12.7) 97 46.8 (12.4) 29.3 % 0.30 [ -3.30, 3.90 ]
Jensen 2016 (2) 116 51.87 (11.653) 119 49.95 (11.653) 42.8 % 1.92 [ -1.06, 4.90 ]
Schmidt 2016 (3) 104 52.9 (13.302) 96 51 (13.302) 27.9 % 1.90 [ -1.79, 5.59 ]
Total (95% CI) 310 312 100.0 % 1.44 [ -0.51, 3.39 ]
Heterogeneity: Chi2 = 0.54, df = 2 (P = 0.76); I2 =0.0%
Test for overall effect: Z = 1.45 (P = 0.15)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Favours Follow-up service Favours Control
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(1) at 12 months
(2) at 12 months
(3) at 6 months
Analysis 1.4. Comparison 1 Follow-up service vs control, Outcome 4 PTSD.
Review: Follow-up services for improving long-term outcomes in intensive care unit (ICU) survivors
Comparison: 1 Follow-up service vs control
Outcome: 4 PTSD
Study or subgroup Follow-up service Control
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
N N IV,Fixed,95% CI IV,Fixed,95% CI
Cuthbertson 2009 89 98 -0.1173 (0.1466) 26.6 % -0.12 [ -0.40, 0.17 ]
Jensen 2016 116 109 -0.146 (0.1336) 32.0 % -0.15 [ -0.41, 0.12 ]
Schmidt 2016 148 143 0.0768 (0.1175) 41.4 % 0.08 [ -0.15, 0.31 ]
Total (95% CI) 353 350 100.0 % -0.05 [ -0.19, 0.10 ]
Heterogeneity: Chi2 = 1.89, df = 2 (P = 0.39); I2 =0.0%
Test for overall effect: Z = 0.61 (P = 0.54)
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours follow-up service Favours control
A D D I T I O N A L T A B L E S
Table 1. Additional data
Study Measurement tool
and time point
Intervention group
dataa
Control group data
a
Effect sizea P valuea
Outcome: HRQoL
Cuthbertson 2009 EQ-5D at 12
months
Mean (SD): 0.58 (±
0.37); n = 108
Mean (SD) 0.60 (±
0.30); n = 113
SMD -0.0, 95% CI
-0.1 to 0.1
0.57
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Table 1. Additional data (Continued)
Outcome: depression and anxiety
Cuthbertson 2009 HADS-D at 12
months
Mean/median not
reported; n = 92
Mean/median not
reported; n = 100
SMD -0.1, 95% CI
-1.2 to 1.0
0.86
Jensen 2016 HADS-D at 12
months
Mean/median data
not reported; n =
130
Mean/median data
not reported; n =
130
Absolute risk reduc-
tion (SCvs interven-
tion) -0.20, 95% CI
-1.12 to 0.72
0.67
Schandl 2012 HADS-D at 14
months
Women: median
(range not reported)
3 ; n = 31;
Men: median (range
not reported) 4; n =
67
Women: median
(range not reported)
7; n = 27;
Men: median (range
not reported) 4; n =
46
Difference between
control and follow-
up groups (negative
values indicate lower
values in follow-up
group); 25th to 75th
percentiles:
Women: 1.7 to -5.4
Men: -0.2 to -1.0
Women: 0.09; Men:
0.47
Cuthbertson 2009 HADS-A at 12
months
Mean (SD) 5.5 (± 4.
6); n = 92
Mean (SD) 6.4 (± 4.
4); n = 100
SMD -0.8, 95% CI
-1.9 to 0.4
0.18
Jensen 2016 HADS-A at 12
months
Mean/median data
not reported; n =
131
Mean/median data
not reported; n =
130
Absolute risk reduc-
tion (SCvs interven-
tion) -0.21, 95% CI
-1.22 to 0.80
0.68
Schandl 2012 HADS-A at 14
months
Women - median
(range not reported)
: 3; n = 31;
Men
- median (range not
reported): 4; n = 67
Women - median
(range not reported)
: 6; n = 27;
Men
- median (range not
reported): 3; n = 46
Difference between
control and follow-
up groups (negative
values indicate lower
values in follow-up
group); 25th to 75th
percentiles:
Women: -1.8 to -3.
2
Men: -0.5 to -0.8
Women: 0.14; Men:
0.78
Outcome: PTSD
Schandl 2012 IES at 14 months Women - median
(range not reported)
: 20; n = 31;
Men - median
(range not reported)
: 16; n = 67
Women - median
(range not reported)
: 31; n = 27;
Men - median
(range not reported)
: 10; n = 46
Difference between
control and follow-
up groups (negative
values indicate lower
values in follow-up
group); 25th to 75th
percentiles:
Women: -6.6 to -17.
Women: 0.01; Men:
0.27
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Table 1. Additional data (Continued)
6
Men: 1.9 to 4.4
Outcome: ability to return to work
Cuthbertson 2009 at 12 months 18 participants re-
turned to work; n =
32
17 participants re-
turned to work; n =
31
OR1.06, 95%CI 0.
35 to 3.21
Not reported
aas reported by study authors
CI: confidence interval; EQ-5D: Euroqol 5D; HRQoL: health-related quality of life; HTQ-IV: Harvard Trauma Questionnaire part
IV;IES: Impact of events scale; n: number of analysed participants;OR: odds ratio; PTSD: post-traumatic stress disorder; SC: standard
care; SD: standard deviation; SMD: standardised mean difference
A P P E N D I C E S
Appendix 1. Search strategies
CENTRAL: the Cochrane Library (Wiley)
1 [mh aftercare] 17505
2 [mh counseling] 4768
3 [mh “long-term care”] 1243
4 MeSH descriptor: [Patient Discharge] explode all trees 1442
5 MeSH descriptor: [Disease Management] explode all trees 3662
6 MeSH descriptor: [Case Management] explode all trees 784
7 (aftercare or after next care or after next treatment):ti,ab 27468
8 (diary or diaries):ti,ab 7973
9 counsel*:ti,ab 10771
10 email?:ti,ab 164
11 telephone*:ti,ab 9482
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(Continued)
12 phone*:ti,ab 4122
13 ((follow* next up or discharge) near/2 (appointment* or con-
sultation* or clinic* or program* or strateg* or service?)):ti,ab
3733
14 (recover* near/2 (appointment* or consultation* or clinic* or
program* or strateg* or service?)):ti,ab
909
15 ((care or case or disease) near management):ti,ab 7581
16 patient discharge:ti,ab 9326
17 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #
11 or #12 or #13 or #14 or #15 or #16
94461
18 [mh “intensive care units”] 3462
19 [mh “multiple trauma”] 216
20 [mh shock] 1615
21 [mh sepsis] 3631
22 [mh “critical illness”] 1604
23 [mh “critical care”] 2193
24 (after or post or discharge? or surviv* or follow* next up):ti,ab 522685
25 #18 or #19 or #20 or #21 or #22 or #23 10168
26 #24 and #25 5056
27 ((after or post or discharge or surviv* or follow* next up) near/
5 (trauma or level 3 or level three)):ti,ab
1514
28 ((after or post or discharge? or surviv* or follow* next up) near/
5 (critical* next (care or ill*))):ti,ab
300
29 ((after or post or discharge? or surviv* or follow* next up) near/
5 (intensive next care or intensive next therapy or intensive next
treatment or icu)):ti,ab
1564
30 ((after or post or discharge? or surviv* or follow* next up) near/5
(sepsis or septicaemi? or septicemi? or bacteremi? or bacteraemi?
or fungaemi? or fungemi? or septic shock or pyaemi? or pyemi?
or pyohemi? or blood next poison*)):ti,ab
677
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(Continued)
31 ((after or post or discharge? or surviv* or follow* next up) near/
5 (serious* next injur*)):ti,ab
6
32 ((after or post or discharge? or surviv* or follow* next up) near/
5 (multiple next organ* next failure* or multiple next organ*
next dysfunction)):ti,ab
32
33 ((after or post or discharge? or surviv* or follow* next up) near/
5 (major next shock)):ti,ab
0
34 ((after or post or discharge? or surviv* or follow* next up) near/
5 (multiple next (trauma or injur* or wound? or fracture?))):ti,
ab
31
35 ((after or post or discharge? or surviv* or follow* next up) near/
5 polytrauma):ti,ab
10
36 #26 or #27 or #28 or #29 or #30 or #31 or #32 or #33 or #34
or #35
8130
37 #17 and #36 1131
38 In trials 1096
MEDLINE (Ovid) including Epub ahead of print, In-process &Other non-indexed citations andMEDLINE <1946 to present>
1 aftercare/ 8001
2 exp counseling/ 42071
3 long-term care/ 25149
4 patient discharge/ 25827
5 case management/ 9904
6 disease management/ 31134
7 (aftercare or after care or after treatment).ti,ab. 162005
8 (diary or diaries).ti,ab. 21651
9 counsel?ing.ti,ab. 81832
10 email?.ti,ab. 5001
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(Continued)
11 telephone*.ti,ab. 54395
12 phone*.ti,ab. 30298
13 ((follow up or discharge) adj2 (appointment* or consultation*
or clinic* or program* or strateg* or service?)).ti,ab
32135
14 (recover* adj2 (appointment* or consultation* or clinic* or
program* or strateg* or service?)).ti,ab
7977
15 ((care or case or disease) adj management).ti,ab. 28675
16 patient discharge.ti,ab. 1207
17 or/1-16 514825
18 exp intensive care units/ 75549
19 exp multiple trauma/ 12812
20 exp shock/ 72960
21 exp sepsis/ 116251
22 exp critical illness/ 24950
23 exp critical care/ 54690
24 (after or post or discharge? or surviv* or follow* up).ti,ab 6050571
25 or/18-23 294460
26 24 and 25 95420
27 ((after or post or discharge or surviv* or follow* up) adj5
(trauma or level 3 or level three)).ti,ab
30714
28 ((after or post or discharge? or surviv* or follow* up) adj5 (crit-
ical* adj (care or ill*))).ti,ab
2818
29 ((after or post or discharge? or surviv* or follow* up) adj5 (in-
tensive care or intensive therapy or intensive treatment or icu)
).ti,ab
14421
30 ((after or post or discharge? or surviv* or follow* up) adj5 (sepsis
or septicaemi? or septicemi? or bacteremi? or bacteraemi? or
fungaemi? or fungemi? or septic shock or pyaemi? or pyemi? or
pyohemi? or blood poison*)).ti,ab
12160
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(Continued)
31 ((after or post or discharge? or surviv* or follow* up) adj5 (se-
rious* adj injur*)).ti,ab
170
32 ((after or post or discharge? or surviv* or follow* up) adj5 (mul-
tiple organ* failure* or multiple organ* dysfunction)).ti,ab
864
33 ((after or post or discharge? or surviv* or follow* up) adj5 (major
adj shock)).ti,ab
0
34 ((after or post or discharge? or surviv* or follow* up) adj5 (mul-
tiple adj (trauma or injur* or wound? or fracture?))).ti,ab
571
35 ((after or post or discharge? or surviv* or follow* up) adj5 poly-
trauma).ti,ab
280
36 or/26-35 135021
37 17 and 36 6733
38 randomized controlled trial.pt. 498494
39 controlled clinical trial.pt. 99301
40 multicenter study.pt. 250271
41 pragmatic clinical trial.pt. 744
42 (randomis* or randomiz* or randomly).ti,ab. 808337
43 groups.ab. 1851829
44 (trial or multicenter or multi center or multicentre or multi
centre).ti
231013
45 (intervention? or effect? or impact? or controlled or control
group? or (before adj5 after) or (pre adj5 post) or ((pretest or pre
test) and (posttest or post test)) or quasiexperiment* or quasi
experiment* or pseudo experiment* or pseudoexperiment* or
evaluat* or time series or time point? or repeated measur*).ti,
ab
8719683
46 non-randomized controlled trials as topic/ 259
47 interrupted time series analysis/ 379
48 controlled before-after studies/ 301
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49 or/38-48 9740756
50 exp animals/ 22541187
51 humans/ 17855892
52 50 not (50 and 51) 4685295
53 review.pt. 2450539
54 meta analysis.pt. 92508
55 news.pt. 189293
56 comment.pt. 726576
57 editorial.pt. 465444
58 cochrane database of systematic reviews.jn. 14562
59 comment on.cm. 726574
60 (systematic review or literature review).ti. 109746
61 or/52-60 8203801
62 49 not 61 6805800
63 37 and 62 3659
Embase (Ovid) <1974 to present>
1 *aftercare/ 2496
2 *follow up/ 30453
3 *long term care/ 19115
4 *hospital discharge/ 10717
5 *disease management/ 5347
6 *case management/ 4762
7 (aftercare or after care or after treatment).ti,ab. 209467
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8 (diary or diaries).ti,ab. 30708
9 counsel?ing.ti,ab. 107800
10 email?.ti,ab. 11229
11 telephone*.ti,ab. 69032
12 phone*.ti,ab. 41772
13 ((follow up or discharge) adj2 (appointment* or consultation*
or clinic* or program* or strateg* or service?)).ti,ab
48699
14 (recover* adj2 (appointment* or consultation* or clinic* or
program* or strateg* or service?)).ti,ab
10327
15 ((care or case or disease) adj management).ti,ab. 36310
16 patient discharge.ti,ab. 1790
17 or/1-16 603291
18 exp *intensive care unit/ 34901
19 *multiple trauma/ 6633
20 exp *shock/ 51084
21 exp *sepsis/ 88888
22 *multiple organ failure/ 5263
23 *critical illness/ 10557
24 exp *intensive care/ 236979
25 (after or post or discharge? or surviv* or follow* up).ti,ab 7611229
26 or/18-24 397085
27 25 and 26 142251
28 ((after or post or discharge or surviv* or follow* up) adj5
(trauma or level 3 or level three)).ti,ab
36940
29 ((after or post or discharge? or surviv* or follow* up) adj5 (crit-
ical* adj (care or ill*))).ti,ab
4356
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30 ((after or post or discharge? or surviv* or follow* up) adj5 (in-
tensive care or intensive therapy or intensive treatment or icu)
).ti,ab
23658
31 ((after or post or discharge? or surviv* or follow* up) adj5 (sepsis
or septicaemi? or septicemi? or bacteremi? or bacteraemi? or
fungaemi? or fungemi? or septic shock or pyaemi? or pyemi? or
pyohemi? or blood poison*)).ti,ab
17614
32 ((after or post or discharge? or surviv* or follow* up) adj5 (se-
rious* adj injur*)).ti,ab
205
33 ((after or post or discharge? or surviv* or follow* up) adj5 (mul-
tiple organ* failure* or multiple organ* dysfunction)).ti,ab
1102
34 ((after or post or discharge? or surviv* or follow* up) adj5 (major
adj shock)).ti,ab
1
35 ((after or post or discharge? or surviv* or follow* up) adj5 (mul-
tiple adj (trauma or injur* or wound? or fracture?))).ti,ab
669
36 ((after or post or discharge? or surviv* or follow* up) adj5 poly-
trauma).ti,ab
374
37 or/27-36 198309
38 17 and 37 9022
39 randomized controlled trial/ 480672
40 controlled clinical trial/ 452801
41 quasi experimental study/ 4143
42 pretest posttest control group design/ 332
43 time series analysis/ 20419
44 experimental design/ 15081
45 multicenter study/ 170777
46 (randomis* or randomiz* or randomly).ti,ab. 1029216
47 groups.ab. 2373186
48 (trial or multicentre or multicenter or multi centre or multi
center).ti
288372
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49 (intervention? or effect? or impact? or controlled or control
group? or (before adj5 after) or (pre adj5 post) or ((pretest or pre
test) and (posttest or post test)) or quasiexperiment* or quasi
experiment* or pseudo experiment* or pseudoexperiment* or
evaluat* or time series or time point? or repeated measur*).ti,
ab
10527848
50 or/39-49 11742553
51 (systematic review or literature review).ti. 123907
52 “cochrane database of systematic reviews”.jn. 6726
53 exp animals/ or exp invertebrate/ or animal experiment/ or
animal model/ or animal tissue/ or animal cell/ or nonhuman/
25514585
54 human/ or normal human/ or human cell/ 19214784
55 48 not (48 and 49) 80230
56 51 or 52 or 55 210760
57 50 not 56 11574665
58 38 and 57 6156
CINAHL (Ebsco)
S1 (MH “After Care”) 9256
S2 (MH “Counseling+”) 28127
S3 (MH “Long Term Care”) 21775
S4 aftercare or after care or after treatment or diary or diaries or
counsel* or email? or telephone* or phone*
362086
S5 ((follow up or discharge) N2 (appointment* or consultation*
or clinic* or program* or strateg* or service?))
9978
S6 (MH “patient discharge”) 12419
S7 (MH “case management”) 14758
S8 (MH “disease management”) 12642
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S9 recover* N2 (appointment* or consultation* or clinic* or pro-
gram* or strateg* or service?)
2486
S10 ((care or case or disease) N0 management) 35925
S11 patient discharge 43812
S12 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR
S9 OR S10 OR S11
449635
S13 (MH “Intensive Care Units+”) 44024
S14 (MH “Multiple Trauma”) 2653
S15 (MH “Multiple Organ Dysfunction Syndrome+”) 11182
S16 (MH “Sepsis+”) 19307
S17 (MH “Critical Illness”) 8606
S18 (MH “Critical Care+”) 21658
S19 S13 OR S14 OR S15 OR S16 OR S17 OR S18 86758
S20 after or post or discharge? or surviv* or follow* up 857022
S21 S19 AND S20 23314
S22 ((after or post or discharge or surviv* or follow* up)N5 (trauma
or level 3 or level three))
28498
S23 ((after or post or discharge? or surviv* or follow* up) N5 (crit-
ical* N0 (care or ill*)))
1448
S24 ((after or post or discharge? or surviv* or follow* up) N5 (in-
tensive care or intensive therapy or intensive treatment or icu)
)
9008
S25 ((after or post or discharge? or surviv* or follow* up)N5 (sepsis
or septicaemi? or septicemi? or bacteremi? or bacteraemi? or
fungaemi? or fungemi? or septic shock or pyaemi? or pyemi?
or pyohemi? or blood poison*))
2391
S26 ((after or post or discharge? or surviv* or follow* up) N5 (se-
rious* N0 injur*))
64
S27 ((after or post or discharge? or surviv* or follow* up) N5 (mul-
tiple organ* failure* or multiple organ* dysfunction))
439
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(Continued)
S28 ((after or post or discharge? or surviv* or follow* up)N5 (major
N0 shock))
0
S29 ((after or post or discharge? or surviv* or follow* up)N5 (major
N0 shock))
0
S30 ((after or post or discharge? or surviv* or follow* up) N5 (mul-
tiple N0 (trauma or injur* or wound? or fracture?)))
151
S31 ((after or post or discharge? or surviv* or follow* up) N5 poly-
trauma)
59
S32 S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR
S28 OR S29 OR S30 OR S31
56366
S33 S12 AND S32 29851
S34 PT randomized controlled trial 57777
S35 PT clinical trial 80067
S36 PT research 1534160
S77 (MH “Randomized Controlled Trials”) 59401
S38 (MH “Clinical Trials”) 133382
S39 (MH “Intervention Trials”) 7169
S40 (MH “Nonrandomized Trials”) 254
S41 (MH “Experimental Studies”) 19334
S42 (MH “Pretest-Posttest Design+”) 34009
S43 (MH “Quasi-Experimental Studies+”) 10642
S44 (MH “Multicenter Studies”) 61668
S45 (MH “Health Services Research”) 11674
S46 TI ( randomis* or randomiz* or randomly)ORAB ( randomis*
or randomiz* or randomly)
202670
S47 TI (trial or effect* or impact* or intervention* or before N5
after or pre N5 post or ((pretest or “pre test”) and (posttest
or “post test”)) or quasiexperiment* or quasi W0 experiment*
or pseudo experiment* or pseudoexperiment* or evaluat* or
1372528
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“time series” or time W0 point* or repeated W0measur*) OR
AB (trial or effect* or impact* or intervention* or before N5
after or pre N5 post or ((pretest or “pre test”) and (posttest
or “post test”)) or quasiexperiment* or quasi W0 experiment*
or pseudo experiment* or pseudoexperiment* or evaluat* or
“time series” or time W0 point* or repeated W0 measur*)
S48 S34 OR S35 OR S36 OR S37 OR S38 OR S39 OR S40 OR
S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47
2258084
S49 S33 AND S48 25958
Appendix 2. Modified ’Risk of bias’ tool
Domain Description Review authors’ judgement
Sequence generation
Allocation concealment
Blinding of participants and personnel
Blinding of outcome assessors
Incomplete outcome data
Selective reporting
Other sources of bias
Baseline outcomes
Contamination
Baseline characteristics
Intervention independent? (ITS)
Appropriate analysis? (ITS)
Shape of effect prespecified? (ITS)
Effect on data collection? (ITS)
Blinding (ITS)
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Incomplete outcome data (ITS)
Selective reporting (ITS)
Other sources of bias (ITS)
ITS: interrupted time series
Appendix 3. GRADE evidence profile
ICU follow-up services compared with standard care or no follow-up service for survivors of critical illness
Quality assessment Effect
Number of
studies and de-
sign
Risk of bias Inconsistency Indirectness Imprecision Other
Health-related quality of life (assessed using EQ-5D; reported at 12 months)
1 randomised
study
Seriousa No serious in-
consistency
No serious indi-
rectness
Seriousb None SMD -0.0, 95% CI -0.1 to
0.1
All-cause mortality (assessed at 2 months in 1 randomised study, at 12 months in 3 randomised studies, and at 14 months in
1 non-randomised study)
4 randomised
studies
1 non-ran-
domised study
No serious risk of
bias
Seriousc No serious indi-
rectness
No serious im-
precision
None RR 0.96, 95% CI 0.76 to
1.22; 4 randomised stud-
ies;1289 analysed partici-
pants
In 1 non-ran-
domised study, number of
deaths in the intervention
group were: 79/259; and in
the control groupwere: 46/
151
Depression and anxiety (assessed using HADS-D and HADS-A; at 12 months in 2 randomised studies, and 12 months in 1
non-randomised study)
2 randomised
studies
1 non-ran-
domised study
Seriousd Seriouse No serious indi-
rectness
Seriousf None For depression:
SMD -0.1, 95% CI -1.2
to 1.0; and absolute risk
reduction (usual care vs
intervention) -0.20, 95%
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CI -1.12 to 0.72; 2 ran-
domised studies
No difference in scores for
depression (women: P = 0.
09; men: P = 0.47) in 1
non-randomised study
For anxiety:
SMD -0.8, 95% CI -1.9
to 0.4; and absolute risk
reduction (usual care vs
intervention) -0.21, 95%
CI -1.22 to 0.80; 2 ran-
domised trials
No difference in scores for
anxiety (women: P = 0.14;
men: P = 0.78) in 1 non-
randomised trial
Post-traumatic stress disorder (PTSD) (assessed using DTS; HTQ-IV, PTSS-10 at 12 months in 3 randomised studies, and
IES at 12 months in 1 non-randomised study)
3 randomised
studies
1 non-ran-
domised study
Seriousg Serioush No serious indi-
rectness
No serious im-
precision
None SMD -0.05, 95% CI -0.19
to 0.10; 703 participants; 3
randomised studies
In
1 non-randomised study,
women who had received a
follow-up service had lower
IES scores (indicating less
chance of PTSD), (P = 0.
01)
Physical function (assessed using PCS of SF-36 at 12 months in 2 randomised studies, and at 2 months in 1 randomised
study, and using SF-8 at 6 months in 1 randomised study)
4 randomised
studies
Seriousi Very seriousj No serious indi-
rectness
No serious im-
precision
None MD 1.31, 95% CI -0.86
to 3.49; 2 non-randomised
studies.
Little or no difference in
physical function at 12
months (P > 0.05) in 1 ran-
domised study
Improved physical func-
tion at 2 months in par-
ticipants who had received
a follow-up service (P = 0.
02) in 1 randomised study
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Cognitive function (assessed using MCS of SF-36 at 12 months in 2 randomised studies, and at 2 months in 1 randomised
study, and using SF-8 at 6 months in 1 randomised study)
4 randomised
studies
Seriousi Very seriousj No serious indi-
rectness
No serious im-
precision
None MD1.44, 95%CI -0.51 to
3.39; 3 randomised stud-
ies.
No difference in cognitive
function at 2 months in 1
randomised study
Ability to return to work (at 12 months)
1 randomised
study
Seriousa No serious in-
consistency
No serious indi-
rectness
Very seriousk None OR 1.06, 95% CI 0.35 to
3.21
Adverse effects
Not measured - - - - - -
aIntervention group received an additional therapy (manual-based physiotherapy programme) which may have influenced outcome
data.
bOne study with few participants.
cAnalysis was at different time points, and we noted some potential differences between studies in baseline characteristics between
studies.
d Intervention group in one study received an additional therapy (manual-based physiotherapy programme), and one non-randomised
study had a high risk of selection bias.
eOutcomes were measured at different time points, and we noted some baseline differences between studies.
fEvidence from few studies.
gIntervention group in one study received an additional therapy (manual-based physiotherapy programme), and one non-randomised
study had a high risk of selection bias.
hWe noted differences at baseline in one non-randomised study (more women in control group had a previous history of psychological
problems) which may have influenced results for this outcome. We noted inconsistent results between three combined randomised
studies and one non-randomised study.
iIntervention group in one study received an additional therapy (manual-based physiotherapy programme), and in another study
intervention group were also involved in preparation of a discharge summary plan. One non-randomised study had a high risk of
selection bias.
jOutcomes were measured at different time points, we noted some baseline differences between studies, and we noted a wide confidence
interval in analysed data.
kOne study with few participants and we noted a wide confidence interval.
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NIHR Cochrane Programme Grant 13/89/16 ’Back to normal’: speed and quality of recovery after surgery, major injury and critical
care
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
We made the following changes to the published protocol (Schofield-Robinson 2017).
Methods (throughout): we planned to include interrupted time-series studies and controlled before-after studies. Because we did not
find these study designs during our search, we removed plans of managing these studies from the review. If future updates include these
study designs, we will incorporate methods published in the protocol.
Types of intervention: we altered the timing of the intervention for clarity. The published protocol stated that the service, “occurs at any
time within six months of discharge” and we changed this to state that the service, “started” within six months. We found that included
studies had follow-up services that were ongoing up to 12 months after ICU discharge and it was not appropriate to exclude these
studies as the design was appropriate for this review. We added extra exclusions (exclusion of rehabilitation services, and exclusion of
assessment of diaries); these were not follow-up services that included a consultation to identify and address unmet needs but, because
these were offered to ICU survivors, we sought to clarify in this section that these studies were distinct from an ICU follow-up service
and were excluded from the review.
Types of outcomes: we altered the time point at which data were collected. The published protocol stated that we would “collect data
for all outcomes at time points measured by study authors up to 12 months post-ICU discharge”. We changed this to collect data “at
the final time point” reported by study authors.
Search methods: we did not search the following grey literature sources because we did not have access to these databases: Healthcare
Management Information Consortium (HMIC); National Technical Information Service (NTIS); or Agency for Healthcare Research
and Quality (AHRQ). We did not contact researchers with expertise in the field, and we did not conduct handsearching of journals
and conference proceedings.
Data collection and analysis: despite our best efforts, we were unable to contact study authors of included studies for additional
information. All data reported in the review were from published records. We did not perform sensitivity analysis, because of the nature
of included studies. Planned sensitivity analyses were: restricting the analysis to published studies; restricting the analysis to studies
with a low risk of selection bias; using available case data or using imputed data (from last observation carried forward) where studies
have missing data.
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